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Abstract 
Porcine circovirus type 2 (PCV2) causes postweaning multisystemic wasting 
syndrome (PMWS) in growing pigs but generally requires the presence of other 
infectious or non-infectious factors to produce the full clinical expression of disease. 
These factors remain to be identified, but management routines, concurrent 
infections and maternal immunity are thought to influence the risk for PMWS 
outbreak in swine herds. Pigs presenting with PMWS develop severe 
immunosuppression and the work of this thesis focuses on the interaction between 
PCV2 and the immune system of the pig in vivo and in vitro. 
Development of PMWS was studied in models for experimental infection in 
young pigs using coinfections with porcine parvovirus (PPV) or Escherichia coli. 
Three-day-old colostrum-deprived pigs infected with PCV2 and PPV developed 
severe PMWS, and a possible role for interleukin 10 as well as impaired production 
of antibodies to PCV2 in the development of disease was observed. Four-week-old 
colostrum fed pigs infected with PCV2 in combination with E. coli did not develop 
clinical disease, but alterations of functions of immune cells were observed ex vivo 
and could be related to the presence of PCV2. 
DNA from virus and bacteria can act modulatory on immune cells through the 
interaction between unmethylated CpG motifs and toll-like receptor (TLR) 9. Five 
sequences with interferon (IFN) alpha-modulatory activity were identified in the 
genome of PCV2, and the inhibitory characteristics of one of these (ODN 
PCV2/1) were studied further in vitro. The ODN was an efficient inhibitor of 
IFN-α production induced in porcine peripheral blood mononuclear cells (PBMCs) 
by other DNA ODNs as well as bacterial or viral DNA, but could not influence the 
IFN-α production induced by synthetic or viral RNA. The inhibition was 
dependent on the ability of ODN PCV2/1 to form secondary structures, but did 
not require the presence of an unmethylated CpG motif. ODN PCV2/1 also 
inhibited the expression of mRNA for other porcine cytokines by PBMC 
stimulated in vitro. 
The presence of immunomodulatory sequences in the genome of PCV2 may 
contribute to evasive mechanisms utilized by the virus during persistent infection of 
immune cells and/or development of clinical disease. 
Keywords: PCV2, PMWS, experimental infection, E. coli, DNA, ODN, IFN-α, 
PBMC, inhibitory, structure, cytokines  
Author’s address: Frida Hasslung Wikström, Department of Biomedical Sciences and 
Veterinary Public Health, Division of Immunology, SLU, BMC P.O. Box 588, 
SE-751 23 Uppsala, Sweden. E-mail: Frida.Wikstrom@bvf.slu.se   4 
 
 
 
 
 
 
 
Till Peter och Elin  
 
Contents 
List of Publications  7 
Abbreviations 9 
Introduction 11 
Porcine Circovirus  11 
Classification of circovirus 11 
Molecular characteristics of PCV  12 
PCV2 infection in vitro 13 
PCV diseases and epidemiology  14 
PCV2 genogroups  14 
Postweaning multisystemic wasting syndrome  15 
Epidemiology 15 
Risk factors for PMWS  16 
Control of PMWS outbreaks  16 
Vaccination 17 
Clinical and pathological presentation of PMWS  17 
Differential diagnoses  18 
Models for experimental reproduction of PCVD  19 
Interaction with the immune system  20 
Humoral immunity to PCV2  20 
Immunosuppression in clinical PMWS  21 
Acute phase protein and cytokine production in PMWS  21 
Interaction between PCV2 and immune cells in vitro 22 
Immunomodulatory DNA  23 
Backbone composition of ODNs  24 
Clinical applications of CpG DNA  24 
Immunomodulatory DNA in pigs  25 
Recognition of immunomodulatory DNA  25 
Toll-like receptors  25 
Non-CpG ligands of TLR9 and alternative receptors for nucleic acids 26 
ODN structure and intracellular processing  27 
Inhibitory DNA motifs  29 
Plasmacytoid dendritic cells  30 
Phenotype and function of PDC  30 
Functions of type I IFNs  31 
Porcine PDC  31  
PCV2, PDC and immunomodulatory DNA  32 
Aims of the present study  33 
Comments on Material and Methods  35 
Experimental infections  35 
Isolation of peripheral blood mononuclear cells  37 
Inducers of IFN-α 37 
Hybridization and denaturation of ODNs  39 
Prediction of secondary structures of ODNs  39 
Methylation of the PCV2 genome  39 
Functional tests of PBMC  39 
Proliferation assay and viability of PBMC  39 
Detection of IFN-α and IFN-α-producing cells  40 
Extraction of RNA and cDNA synthesis  40 
Detection and quantification of cytokine mRNA  41 
Results and Discussion  43 
Experimental infections  43 
Clinical and pathological expression of disease  44 
Humoral response to PCV2 and PPV  45 
Viral load and in vitro functions of PBMC  46 
IFN-α and IL-10 in serum  46 
Immunomodulatory sequences in the PCV2 genome  48 
Identification of CpG motifs  48 
Inhibitory activity of ODN PCV2/1  48 
Secondary structure of ODN PCV2/1  50 
Secondary structure of Class A ODNs  51 
Function of ODN PCV2/1  52 
Importance of immunomodulatory sequences in the PCV2 genome  55 
Conclusions 57 
Aspects on future work  59 
References 61 
Acknowledgements 75   7 
List of Publications 
This thesis is based on the work contained in the following papers, referred 
to by Roman numerals in the text: 
 
I  Hasslung, F., Wallgren, P., Ladekjær-Hansen, A-S., Bøtner, A., Nielsen, 
J., Wattrang, E., Allan, G.M., McNeilly, F., Ellis, J., Timmusk, S., Belák, 
K., Segall, T., Melin L., Berg, M. and Fossum, C. (2005). Experimental 
reproduction of postweaning multisystemic wasting syndrome (PMWS) 
in pigs in Sweden and Denmark with a Swedish isolate of porcine 
circovirus type 2. Vet Microbiol 106, 49-60. 
II  Hasslung Wikström, F., Wallgren, P., Blomqvist, G., Belák, K., Tenk, 
M., Fuxler, L., Wolff, C., McNeilly, F., Krakowka, S., Allan, G.M. and 
Fossum, C. Experimental co-infection of 4-week-old colostrum fed pigs 
with PCV2 and E. coli (manuscript). 
III Hasslung, F.C., Berg, M., Allan, G.M., Meehan, B.M., McNeilly, F. and 
Fossum, C. (2003). Identification of a sequence from the genome of 
porcine circovirus type 2 with an inhibitory effect on IFN-α production 
by porcine PBMCs. J Gen Virol 84, 2937-2945. 
IV Wikström, F., Meehan, B.M., Berg, M., Timmusk, S., Elving, J., Fuxler, 
L., Magnusson, M., Allan, G.M., McNeilly, F. and Fossum, C. (2007). 
Structure-Dependent Modulation of Alpha Interferon Production by 
Porcine Circovirus 2 Oligodeoxyribonucleotide and CpG DNAs in 
Porcine Peripheral Blood Mononuclear Cells. J Virol 81(10), 4919-4927. 8 
V  Hasslung Wikström, F., Fossum, C., Fuxler, L. and Lövgren, T. DNA 
sequence motif in the genome of porcine circovirus type 2 inhibits 
production of cytokines by peripheral blood mononuclear cells in vitro 
(manuscript). 
Papers I, III and IV are reproduced with the permission of the publishers. 
   9 
Abbreviations 
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Introduction 
Porcine Circovirus 
Porcine circovirus (PCV) was first discovered as a contaminant, 
morphologically similar to picornavirus, in cultures of the continuous 
porcine kidney cell-line PK15 (Tischer et al., 1974). It was later described as 
a single-stranded DNA (ssDNA) virus with a circular genome, and was 
consequently assigned to the family Circoviridae (Tischer et al., 1982). Since 
no disease or cytopathic effect could be associated with the virus, it was 
believed to be apathogenic although serological surveys revealed that it was 
widely spread in the pig population (Allan et al., 1995; Tischer et al., 1986). 
In 1996, however, PCV was associated with outbreaks of wasting disease 
later referred to as postweaning multisystemic wasting syndrome (PMWS) in 
young pigs in western Canada. (Ellis et al., 1998). This virus was similar but 
not identical to the PCV previously described, the nucleotide (nt) sequence 
identity was shown to be less than 80% with the original virus (Meehan et 
al., 1998), and PCV was subsequently divided into two types; PCV1 
representing the apathogenic virus that was first described, and PCV2 the 
newly isolated virus associated with clinical disease. 
Classification of circovirus 
Porcine circovirus belongs to the family Circoviridae that contains two 
genera apart from circovirus; gyrovirus and anellovirus, classified according to 
their morphology and genomic organization. Circovirus is the largest group 
with members mainly infecting birds (Todd 2004). Apart from porcine 
circovirus, the only mammal that has been reported infected with a 
circovirus is cattle, but the data is limited to one study (Nayar et al., 1999) 12 
and it is uncertain whether a unique bovine circovirus really exist or if it is a 
variant of porcine circovirus (Fenaux et al., 2000). The genus anellovirus is 
represented by Torque teno virus (TTV) and Torque teno mini virus 
(TTMV) that have been detected in a number of species including human 
and pig, although the association of the viruses with disease is so far not clear 
(Hino and Miyata 2007). Chicken anemia virus was initially identified as a 
circovirus but was later reclassified and is until date the only member of the 
genus  gyrovirus. A common trait for Chicken anemia virus and most 
members of the genus circovirus is that they are associated with diseases that 
present with severe immunosuppression as a primary characteristic (Todd 
2004). 
Molecular characteristics of PCV 
Porcine circovirus is one of the smallest autonomously replicating viruses 
known, the virion is approximately 17 nm in diameter, and the single 
stranded (ss) DNA genome of PCV consists of a covalently closed circle of 
approximately 1.7 kb (Fig. 1). Six potential open reading frames (ORFs) 
larger than 200 nt have been identified within the genome, but functional 
proteins have so far only been shown to be expressed by two of these 
(Segalés et al., 2005). ORF1 codes for the replicase proteins, Rep and Rep´, 
and ORF2 for the structural capsid protein, Cap, and the genes are arranged 
in a clockwise and counter-clockwise manner resulting in an ambisense 
organization of the genome (Mankertz et al., 2004).  
 
ORF1 ORF2 EcoRI
OR
 
Figure 1. Genomic organization of PCV. ORF1 is located on the clockwise plus strand and 
encodes the replication proteins Rep and Rep´. ORF2 is located on the counter clockwise 
strand and encodes the structural capsid protein Cap. The origin of replication (OR) is 
positioned adjacent to the stem loop in the intergenic region and the EcoRI cleavage site is 
located in ORF2.   13 
A third open reading frame, ORF3, was also described, but the 
identification of a protein and its function is still under debate although it 
has been suggested that the ORF3 protein is involved in the viral 
pathogenesis via an apoptotic function (Liu et al., 2007; Liu et al., 2005). 
Circoviruses replicate via rolling circle replication (RCR) involving an 
intermediate double-stranded (ds) replicative form of DNA and this form of 
replication has been suggested for PCV as well (Cheung 2006; Meehan et 
al., 1997). Since the virion carries only a very limited amount of 
information, the virus is dependent on cellular DNA polymerases for its 
replication. PCV replication is initiated when the Rep proteins binds to 
short hexamer repeats in the intergenic region adjacent to the stem loop, 
also referred to as the origin of replication (OR) (Mankertz et al., 2004). 
During replication, the Rep proteins nick and join the nucleotide segments 
at the initiation and termination of the replication cycle while the cellular 
polymerases are responsible for the synthesis of DNA (Cheung 2006; 
Steinfeldt et al., 2006). 
PCV2 infection in vitro 
Although a primary cell for PCV2 replication in vivo has not yet been 
identified, in vitro studies on the infection of PCV2 in different cell types 
have generated valuable information on the mechanisms of infection. PCV2 
is consistently found in the cytoplasm of monocytes, macrophages and 
dendritic cells (DC), but the absence of replicative ds DNA intermediates 
and infectious virus progeny indicate that replication does not take place in 
these cells (Gilpin et al., 2003; Vincent et al., 2003). A specific receptor for 
PCV2 entry into cells has not yet been found, but the glucosaminoglycans 
heparan sulfate and chondroitin sulfate B have been identified as attachment 
receptors for PCV2 on monocytes (Misinzo et al., 2006; Misinzo et al., 
2005). These structures are common to several viruses as receptors, and it 
has been suggested that PCV2 is internalized in monocytes and DC via 
clathrin-mediated endocytosis (Misinzo et al., 2006; Vincent et al., 2005).  
In addition, the infection of monocytic cells by PCV2 has been 
demonstrated to depend on the acidic environment provided through the 
endosome-lysosome system acidification (Misinzo et al., 2005). In epithelial 
cells, however, chloroquine inhibition of the same mechanism of 
acidification in the early stages of infection enhanced the replication of 
PCV2. Chloroquine was demonstrated to interfere with the disassembly of 
the PCV2 capsid that in turn is mediated by a serine protease (Misinzo et al., 
2008b). In addition, enhanced PCV2 replication was observed when 
epithelial and monocytic cells were treated with interferon (IFN)-γ, 14 
probably related to an enhanced internalization of the virus (Meerts et al., 
2005), and the virus replication in epithelial cells could be increased further 
by combining IFN-γ treatment with inhibition of endosomal acidification 
(Misinzo et al., 2008a). In vitro studies have also revealed enhanced 
replication of PCV2 in alveolar macrophages in the presence of 
lipopolysaccharide (LPS) (Chang et al., 2006). In summary, the 
characteristics of PCV2 infection seem dependent on the cell type that it 
enters, and no specific receptor for viral uptake and entry has yet been 
identified. 
PCV diseases and epidemiology 
There has been much debate concerning the association between PCV2 and 
PMWS due to initial difficulties in fulfilling the criteria of Koch’s postulate. 
It is now, however, generally accepted that PCV2 is a necessary agent 
causing PMWS although other factors are needed in combination with 
PCV2 to produce the full clinical expression of disease. PMWS is 
consequently described as a multifactorial disease. PCV2 is also discussed in 
association with other severe disease syndromes of pigs such as porcine 
dermatitis and nephropathy syndrome (PDNS), porcine respiratory disease 
complex (PRDC) and reproductive disorders, and even though the scientific 
evidence for links with these diseases is still not complete, the term PCV 
diseases (PCVD) is now used (Segalés et al., 2005).  
PCV2 has been widely spread in pig populations world wide for several 
years without the presence of PMWS, and retrospective studies have 
detected PCV2 antigen or antibodies to the virus in material collected from 
pigs as early as 1969 (Opriessnig et al., 2007). In Sweden, serological surveys 
detected antibodies to PCV2 in 80.5% of the pigs sampled for the national 
control program for Aujeszky´s disease in 2000 (Wallgren et al., 2007). The 
virus was first isolated in Sweden from a clinically healthy pig in a high 
health specific pathogen free (SPF) farm experiencing an outbreak of 
exudative epidermitis and reproductive disturbances in 1993 (Wattrang et 
al., 2002). It is probable that PCV2 was present in the country for some 
time prior to this event, although the first case of PMWS in Sweden was not 
diagnosed until ten years later (Wallgren et al., 2004). 
PCV2 genogroups 
Recently there have been several reports from various parts of the world on 
the emergence of different distinct genogroups of PCV2 (Dupont et al., 
2008, Grau-Roma et al., 2008; Timmusk et al., 2008; Cheung et al., 2007).   15 
In some studies it has been indicated that certain genogroups of PCV2 may 
be more strongly associated with outbreaks of PCVD than others (Grau-
Roma et al., 2008; Timmusk et al., 2008; Opriessnig et al., 2006b) whereas 
not such correlation has been found in several studies (Allan et al., 2007; 
Olvera et al., 2007; de Boisséson et al., 2004). In Denmark, a survey of 
PMWS outbreaks indicated that the introduction of a novel pathogen could 
be associated with the rapid spread of PMWS (Vigre et al., 2005). There are 
a rapidly increasing number of publications on this subject, and it is now 
more or less accepted that PCV2 can be classified into genogroups or 
clusters although no consensus has been reached regarding the effect on 
disease development, or definition and nomenclature. 
Postweaning multisystemic wasting syndrome 
Epidemiology 
The first cases of wasting disease among weaning pigs were identified in 
high health herds in western Canada in 1991, and the term postweaning 
multisystemic wasting syndrome was later proposed based on the 
characteristic clinical presentation and histopathological lesions (Clark 1996; 
Harding 1996). Further examination of pigs presenting with PMWS 
revealed an abundance of PCV nucleic acid and antigen in association with 
lesions in several tissues (Ellis et al., 1998). Independently of these 
observations, in 1996, pig producers in Brittany, France, experienced 
unexpectedly high losses among growing pigs that mainly presented with 
wasting (Madec et al., 2000). PCV was also isolated from these animals, and 
the disease was later defined as PMWS. During the following decade, 
PMWS spread over the world and is today a major problem with large 
economic impact in most pig-producing countries. The morbidity of the 
disease varies between herds commonly ranging between 4-30%, although 
numbers as high as 60% have been reported, and the mortality among 
affected pigs can be 70-80% (Segalés and Domingo 2002). In Sweden, the 
first case of PMWS was reported in 2003, and since then the disease has 
spread rapidly and is now endemic in the country (Wallgren et al., 2007; 
Wallgren et al., 2004). Although the extensive spread of the disease, the total 
losses postweaning in PMWS affected farms have been relatively low in 
Sweden compared to what has been reported from other countries, normally 
ranging between 4-10% with occasional reports of 15% (Wallgren et al., 
2007). 16 
Risk factors for PMWS 
PMWS is defined as a multifactorial disease where PCV2 in combination 
with other so far poorly identified infectious or non-infectious factors is 
required for the full clinical expression (Segalés et al., 2005). Several 
epidemiological studies have been conducted in order to identify factors that 
influence the risk for PMWS outbreaks and some implications mainly 
concerning management routines have been made. The risk for developing 
PMWS is increased in large herds (Wallgren et al., 2007; Woodbine et al., 
2007), when there is a high degree of cross-fostering and when the empty 
period between batches is short (Wallgren et al., 2007: Rose et al., 2003). 
The presence of concurrent infections within the herd has also been studied 
and a correlation between PMWS and porcine reproductive and respiratory 
syndrome virus (PRRSV) has been indicated in several reports (Kawashima 
et al., 2007; Wellenberg et al., 2004; Woodbine et al., 2007; Rose et al., 
2003). Other pathogens that have been found in association with PCVD are 
porcine parvovirus (PPV), swine influenza virus, Mycoplasma hyopneumoniae, 
swine hepatitis E virus and Aujeszky´s disease virus (ADV) (Ellis et al., 
2004), but the nature of the interaction between PCV2 and these agents, 
and the mechanisms resulting in development of clinical disease are yet to be 
determined. The results from in vitro studies showing enhanced replication 
of PCV2 in the presence of IFN-γ or LPS indicate, however, a role for 
concurrent viral and bacterial infections in the development of PMWS.  
There have been several observations of deviations from management 
routines in well-organized farms that subsequently broke down with PMWS 
(Wallgren et al., 2007; Madec et al., 2000). There are also field reports of 
differences in development of PMWS between litters or boar lines (Allan 
and McNeilly 2006; Madec et al., 2001) indicating a potential genetic 
component of importance in the disease process although these observations 
remain to be confirmed in controlled studies designed for this purpose. The 
transfer of adequate passive immunity from the sow is, however, an 
important factor that decreases the risk for developing PMWS among 
weaning pigs (Rose et al., 2007) and may appear as a litter effect during 
PMWS outbreaks. 
Control of PMWS outbreaks 
Although the scientific data is limited, there is a general consensus that the 
high stress level of intensified rearing systems is a contributor to PMWS 
outbreaks. This was early pointed out by Madec and co-workers, and as a 
result of this a 20 point plan of recommendations for adjustments of housing 
and management routines in farms affected by PMWS was proposed (Madec   17 
et al., 2001). The plan was mainly designed to reduce overall stress and 
improve hygiene and infection status within the herd, and results from 
preliminary studies were encouraging. Today, these interventions are 
implemented as a guideline for the control of postweaning mortality in 
PMWS affected farms in several countries, and the reports show positive 
results on the losses associated with PMWS (Allan and McNeilly 2006; 
Segalés et al., 2005). 
Vaccination 
Apart from Madec´s 20-point plan, vaccination is being evaluated as a 
possible way of controlling PMWS, and reports of decreased problems with 
postweaning mortality in PMWS affected farms after vaccination have so far 
been encouraging (Opriessnig et al., 2007). There are today four 
commercially available vaccines against PCV2, but only one of these is until 
date registered for use in Europe (Circovac, Merial) whereas the other three 
are registered in the US and/or Canada (Ingelvac CircoFLEX, Boeringer 
Ingelheim; Suvaxyn PCV2 One Dose, Fort Dodge; Circumvent PCV, 
Intervet). The vaccines use two different approaches for establishing 
protective immunity against PCV2 in growing pigs. The vaccines from 
Boeringer Ingelheim, Fort Dodge and Intervet are used as single or dual 
injections of young pigs from 3-4 weeks of age whereas the Merial vaccine 
is administered to sows 2-4 weeks prior to farrowing in order to ensure 
effective transfer of passive immunity to the offspring (Charreyre et al., 
2006). Although preliminary data on the effect of vaccination of young pigs 
has been encouraging, it should be borne in mind that PCV2 replication was 
potentiated in experimentally infected pigs following administration of some 
commercially available vaccines, probably due to the adjuvant component 
(Krakowka et al., 2007). Thus, vaccination of young pigs could by itself be a 
risk factor for development of PMWS. Field studies have, however, 
reported no increase of morbidity in PMWS-affected farms following 
vaccination against PRRSV and Mycoplasma hyopneumoniae using 
commercial vaccines (Kritas et al., 2007; Haruna et al., 2006). 
Clinical and pathological presentation of PMWS 
Pigs presenting with PMWS are usually 8-16 weeks of age, and the most 
prominent clinical symptom is progressive weight loss, i.e. wasting 
(illustrated in Figure 2), but other signs such as respiratory distress, diarrhea, 
pallor, jaundice and visibly enlarged lymph nodes may occur to a varying 
degree (Segalés et al., 2005; Allan and Ellis 2000). Gross lesions of PMWS 18 
are variable, but commonly include pale and enlarged lymph nodes and 
mottled and firm lungs that fail to collapse (Allan and Ellis 2000). In 
advanced stages of disease, atrophy of lymph nodes and thymus has been 
observed (Segalés et al., 2005). Although the clinical symptoms and gross 
lesions may be unspecific in some pigs, the histopathological lesions of 
PMWS are unique. These include generalized lymphadenopathy 
characterized by infiltration of histiocytic cells and multinucleated giant cells 
and marked depletion of T  and B lymphocytes. Histiocytic inflammatory 
infiltrates with multinucleated giant cells may be found in a number of 
organs, and interstitial pneumonia, hepatitis and nephritis are regular findings 
in PMWS diseased pigs. In early to mid-stages of PMWS, cytoplasmic 
inclusion bodies in mononuclear phagocytes and an abundance of PCV2 
antigen and/or nucleic acid can be detected in association with the lesions 
(Allan and Ellis 2000). As a result of the severe damage to the lymphoid 
tissues, the immunological defense of pigs in advanced stages of PMWS is 
impaired, rendering them susceptible to secondary infections (Segalés et al., 
2005).  
 
Figure 2. Growing pigs with clinical PMWS presenting with wasting. Not all pigs in the pen 
are affected, but diseased pigs are significantly thinner with a visible spine and more fur. 
(Photos reproduced with kind permission from Michael Stampe, Svenska Djurhälsovården) 
Differential diagnoses 
There are several important differential diagnoses that should be considered 
upon confirmation of PMWS. Among these are classical swine fever, 
pseudorabies, and porcine reproduction and respiratory syndrome (PRRS). 
These infections are fortunately not present in Sweden today, but should be   19 
considered none the less. Other differential diagnoses that are relevant also 
within the Swedish pig production are porcine intestinal adenomatosis 
(Lawsonia intracellularis), swine dysentery and porcine colonic spirochetosis 
(Brachyspira hyodysenteriae and pilosicoli, respectively), postweaning 
colibacillosis, swine enzootic pneumonia (Mycoplasma hyopneumoniae) and 
actinobacillus pleuropneumonia (Segalés et al., 2005). In fact, 37% of the 
Swedish herds diagnosed with PMWS had concurrent problems with 
infections of L. intracellularis,  M. hyopneumoniae,  A. pleuropneumoniae, 
Brachyspira spp or E. coli. After treatment for these infections and correction 
of management routines, the postweaning mortality decreased markedly 
(Wallgren et al., 2007). 
Models for experimental reproduction of PCVD 
Several models for experimental reproduction of PMWS have been 
established since the association between PCV2 and PMWS, and these have 
generated fundamental understanding of the disease mechanisms in PCVD. 
From trials using young gnotobiotic (GN) or colostrum deprived (CD) pigs, 
several studies reported that infection with PCV2 could reproduce PMWS 
but a concurrent infection with PPV or immune stimulation using keyhole 
limpet hemocyanin and incomplete Freund´s adjuvant (KLH/ICFA) resulted 
in more severe clinical disease and pathological lesions (Allan et al., 2004). 
Co-infection with PRRSV also resulted in severe clinical disease in CD pigs 
(Harms et al., 2001) and potentiated PCV2 replication in experimental 
infections (Allan et al., 2000). In addition, a synergistic effect of PRRSV and 
PCV2 on the depletion of immune cells has been reported in combination 
with a delayed seroconversion and prolonged viremia compared to pigs that 
were infected with either virus alone (Shi et al., 2007). Dual infection with 
PCV2 and Mycoplasma hyopneumoniae also resulted in more severe PCV2-
associated lesions and higher amount of viral antigen (Opriessnig et al., 
2004).  
In attempts to reproduce PMWS in older, colostrum fed animals, the 
results have varied greatly regardless of co-infections or immune stimulation. 
Some studies report severe clinical disease in up to 67% of the animals 
(Stevenson et al., 2006; Allan et al., 2004; Ladekjær-Mikkelsen et al., 2002), 
whereas in other studies only a subclinical infection with mild gross and 
histological lesions could be detected (Ostanello et al., 2005; Magar et al., 
2000; Balash et al., 1999). These differences may partly be explained by 
variations in passive immunity among inoculated pigs (McKeown et al., 
2005; Ostanello et al., 2005). 20 
Interaction with the immune system 
Humoral immunity to PCV2 
Studies on naturally and experimentally infected pigs have revealed 
important information on the development of adaptive antibody mediated 
immunity to PCV2 and how it may affect the expression of PMWS. Passive 
immunity through maternal antibodies has been shown to protect from 
PMWS outbreak in a dose-dependent manner (Rose et al., 2007; McKeown 
et al., 2005). It is not only the supply of colostrum that is of importance, but 
the PCV2 infection status of the sow may influence the protection of the 
offspring. Sows with low levels of PCV2 antibodies had a higher percentage 
of offspring affected by PMWS (Calsamiglia et al., 2007). Furthermore, 
presence of PCV2 antibodies is not necessarily protective since not all 
antibodies are neutralizing for PCV2 infection. Experimentally infected pigs 
commonly seroconvert to PCV2 between 14 and 28 days post infection 
(Segalés et al., 2005) but PMWS-affected pigs have shown a delayed and 
weak response and neutralizing antibodies have been detected later or not at 
all in these animals (Fort et al., 2007; Meerts et al., 2006; Meerts et al., 
2005; Okuda et al., 2003; Bolin et al., 2001; Pogranichniy et al., 2000). The 
low levels of neutralizing antibodies could also be correlated to high levels of 
PCV2 replication (Fort et al., 2007; Meerts et al., 2005). Pigs with low 
levels of neutralizing antibodies also had decreased production of total 
antibodies to PCV2 indicating that PMWS affected pigs have an impaired 
humoral response to PCV2 that subsequently results in a higher viral load 
(Fort et al., 2007; Meerts et al., 2005).  
In field conditions, the pigs are generally protected against PCV2 
infection by the passive immunity transferred from the sow during the first 
weeks of life and active seroconversion to PCV2 usually occurs between 
7-12 weeks of age (Segalés et al., 2005). If the window between the decline 
of maternal immunity and onset of active seroconversion where the pigs are 
not protected is extended due to an impaired humoral response, the risk for 
developing PMWS following infection with PCV2 may increase. 
The major immunorelevant B-cell epitopes of PCV2 have been detected 
within the structural capsid protein and several studies report similar 
locations of these epitopes (Shuai et al., 2007; Lekcharoensuk et al., 2004; 
Truong et al., 2001; Mahe et al., 2000). These areas of the protein seem to 
possess a certain degree of variability in amino acid sequence, and potential 
differences within epitopes of PCV2 isolates originating from various genetic 
and clinical backgrounds have been reported (Lefebvre et al., 2008; 
Timmusk et al., 2008; Kim and Lyoo 2002). Few studies have so far been   21 
performed in order to characterize the T-cell epitopes of PCV2. According 
to the published data, these epitopes seem, in contrast to the B-cell epitopes, 
to be located on the nonstructural proteins of ORF1 and ORF3 (Stevenson 
et al., 2007). 
Immunosuppression in clinical PMWS 
Several reports have discussed the immunodeficiency induced by PMWS in 
affected pigs and the complex interaction between the immune system and 
PCV2 during disease (Segalés et al., 2004a; Darwich et al., 2002; Krakowka 
et al., 2002). The most striking immunologic feature of clinical PMWS is 
the marked depletion of lymphocytes from lymphoid tissue and the 
replacement with histiocytes and macrophages (Krakowka et al., 2002). In 
PMWS affected animals, this alteration in cell composition is preceded by 
leukopenia affecting B  lymphocytes as well as helper, cytotoxic and 
γδ TCR-expressing T cells and natural killer (NK) cells but not granulocytes 
or monocytes (Nielsen et al., 2003; Segalés et al., 2001). The depletion of 
lymphocytes has been suggested to be a result of apoptosis, but the evidence 
for this theory is still lacking. PCV2 is generally not recovered from 
lymphocytes, and interaction with PCV2-infected dendritic cells in fact 
seemed to increase the survival of the lymphocytes (Vincent et al., 2003). 
This indicates that PCV2 infection of DC is not responsible for the 
lymphocyte depletion in severe cases of PMWS. 
Acute phase protein and cytokine production in PMWS 
In comparison with subclinically infected pigs, serum levels of the acute 
phase proteins (APP) haptoglobin, pig-major acute phase protein (pig-
MAP), C-reactive protein (CRP), serum amyloid A (SAA) and albumin 
increased in PMWS-affected pigs (Parra et al., 2006; Stevenson et al., 2006; 
Segalés et al., 2004b). Attempts to characterize the expression of cytokines in 
lymphoid tissues and peripheral blood mononuclear cells (PBMC) from pigs 
that present with clinical PMWS have so far not generated a common 
pattern of cytokine production, and the classification of the immune 
response into a T helper (Th) 1 type has been debated (Sipos et al., 2004; 
Darwich et al., 2003). Nevertheless, increased expression and production of 
interleukin (IL)-10 have been found in several independent studies 
indicating that it may be involved in the development of disease (Stevenson 
et al., 2006; Sipos et al., 2004; Darwich et al., 2003). The IL-10 production 
has been detected as increased mRNA expression in thymus in association 
with histopathological lesions (Darwich et al., 2003) and in PBMC (Sipos et 
al., 2004) of PMWS-affected pigs. In experimentally infected pigs, elevated 22 
levels of IL-10 were detected in serum of pigs that subsequently developed 
clinical PMWS (Stevenson et al., 2006), and a correlation between viremia 
and increased expression of IL-10 during subclinical PCV2 infection has 
been reported (Darwich et al., 2008). 
Altogether these data suggest a severe immunosuppression of pigs that 
develop clinical PMWS, but the underlying mechanisms are still poorly 
understood. The expression of cytokines detected in clinically affected pigs 
may be an effect of the disease rather than the cause of PMWS. This may 
partially explain the diverging results reported in previous studies due to the 
different phases of disease in which the cytokine expression was observed. 
Interaction between PCV2 and immune cells in vitro 
PCV2 infects cells of the monocytic lineage, including macrophages and 
DC, but does not seem to be replicating in these cells (Gilpin et al., 2003; 
Vincent et al., 2003). In fact, there is little effect on the viability and 
function of the cells, and the infection appears silent and persistent for an 
extended period of time. DC infected with PCV2 in vitro do not alter their 
expression of major histocompatibility complex (MHC) class I and II or 
cluster of differentiation (CD) 80/86, even after exposure to IFN-α and 
tumor necrosis factor (TNF)-α, indicating that PCV2 does not induce or 
interfere with maturation of the DC (Vincent et al., 2005, Vincent et al., 
2003). The same studies also showed that PCV2 infection seemingly has no 
effect on the antigen presenting and processing ability of DCs as 
demonstrated by infections with foot and mouth disease virus (FMDV) or 
classical swine fever virus (CSFV) (Vincent et al., 2005). In addition, the 
infectivity of PCV2 was unaltered and the virus was not transmitted from 
infected DCs to syngeneic T cells even after stimulation of the lymphocytes 
(Vincent et al., 2003). 
These results illustrate a potential mechanism used by PCV2 to escape the 
immune response of the host, and to be disseminated throughout the body 
via the circulation of DCs. There are, however, reports on altered function 
of immune cells from PMWS-affected animals. In response to recall antigen 
(PCV2), PBMC from clinically affected pigs responded with an increased 
production of IL-10 and IFN-γ compared to PBMC from infected healthy 
pigs, and displayed an impaired ability to produce IL-4, IL-2 and IFN-γ 
upon stimulation with mitogen or superantigen (Darwich et al., 2003). 
These results indicate a detrimental effect on immune cells by PCV2 in late 
stages of disease, but it does not explain the apparently silent infection found 
in subclinically infected animals. The immunomodulatory activity of PCV2 
on DCs in vitro has been ascribed to the presence of viral DNA rather than   23 
the whole virion (Vincent et al., 2007), and this may be correlated to the 
presence of specific Immunomodulatory sequence motifs within the genome 
of PCV2. 
Immunomodulatory DNA 
In 1992 Yamamoto and coworkers reported activation of immune functions 
including production of IFNs and activation of NK cells induced by the 
bacterial DNA component of Mycobacterium bovis BCG. The effect was 
specific for bacterial DNA and could not be repeated using vertebrate DNA 
(Yamamoto et al., 1992). The effect of immunostimulatory DNA (IS-DNA) 
was later ascribed to the presence of single-stranded palindromic sequences 
containing unmethylated cytosine-phosphate-guanine (CpG) dinucleotides 
surrounded by a specific pattern of nucleotides forming hexameric CpG 
motifs (Sato et al., 1996; Krieg et al., 1995). CpG dinucleotides are present 
in both microbial and vertebrate genomes, but their number is suppressed in 
vertebrates reaching only 25% of the expected random frequency. In 
addition, about 80% of the cytosines in CpG dinucleotides of vertebrate 
genomes are methylated (Krieg 2007a). Consequently, unmethylated CpG 
DNA is recognized as a danger signal following microbial infection. In 
human DC and B cells, CpG DNA interacts with the pattern recognition 
receptor (PRR) toll-like receptor (TLR) 9 within the endosomal 
compartment (Ishii and Akira 2006). 
Using synthetic oligodeoxyribonucleotides (ODNs), the immuno-
stimulatory activity of CpG DNA has been studied in detail. The optimal 
nucleotide sequences for immunostimulation by CpG motifs vary between 
species, and various ODN constructs have different effects on the 
immunological response. From studies predominantly using human cells, 
three major classes of ODNs with distinct properties have been established. 
A-class, or D, ODNs are potent inducers of IFN-α in plasmacytoid 
dendritic cells (PDC) also referred to as natural interferon producing cells 
(NIPC), but does not activate B  cells. B-class, or K, ODNs strongly 
stimulate B  cells to proliferate and secrete antibodies, but are only weak 
inducers of IFN-α. C-class ODNs has combined the characteristics of class 
A and B ODNs and induces both IFN-α production and B-cell activation 
(Krieg 2007a). This definition of ODN classes was, however, established 
using human and murine cells, and variations in ODN activity have been 
reported in other species. In fact, equine and ovine PBMC respond with 
IFN-α production to stimulation with B-class ODNs (Wattrang et al., 2007; 
Mena et al., 2003). 24 
Backbone composition of ODNs 
Due to the rapid degradation by nucleases of ODNs constructed with the 
natural phosphodiester (PO) backbone, ODNs are often synthesized with a 
resistant phosphorothioate (PS) backbone where a nonbridging oxygen has 
been replaced by a sulphur (Stein et al., 1988). B-class and C-class ODNs 
are by definition phosphorothioates, whereas class A ODNs have a chimeric 
backbone of both PO- and PS-nucleotides. PO-ODNs have been described 
as potent IFN-α inducers in human and porcine PBMC, but generally 
require incorporation in cationic lipids to function (Domeika et al., 2004; 
Magnusson et al., 2001), presumably to protect from nuclease activity and to 
facilitate cellular uptake (Honda et al., 2005; Gursel et al., 2001; Xu and 
Szoka 1996). Phosphorothioate modification of the ODN backbone also 
affects the specific sequence requirements of the interaction with TLR9. 
PS-ODNs are less flexible than PO-ODNs and have been described as 
”sticky” due to unspecific binding to several proteins including TLRs 
(Yasuda et al., 2006). 
Clinical applications of CpG DNA 
The possible use of CpG ODNs within several clinical applications has been 
suggested, and there is much interest in the research and development of 
such products. Due to the strong immunostimulatory activity of CpG DNA, 
B-class ODNs are widely used as adjuvant components in the development 
of vaccines (Krieg 2007a; Klinman 2004). The CpG ODNs induce powerful 
antigen-specific antibody and Th1 cellular immune responses, and the effect 
can be further modified by combination with other types of adjuvants. 
ODNs used in vivo as vaccine adjuvants have so far only been B-class PS-
ODNs (Krieg 2007a). The safety of the PS-ODNs in these studies has been 
satisfying, but adverse effects such as lymphadenopathy and 
immunosuppression have been reported after repeated injections in rodents 
(Heikenwalder et al., 2004; Lipford et al., 2000). Induction of a Th1-type 
immune response by CpG ODNs has opened for a possible application as 
therapy against intracellular infections, and C-class ODNs are currently 
being evaluated for possible therapeutic use against hepatitis C virus (Krieg 
2007a). The potentiation of T cell responses by CpG DNA is also used to 
increase anti-tumor activity in anticancer agents, and the Th1 bias induced 
by CpG ODNs can inhibit the production of Th2 cytokines and thereby 
CpG ODNs are promising candidates to be used therapeutically in asthma 
(Klinman 2004).   25 
Immunomodulatory DNA in pigs 
Most studies on immunomodulatory DNA have been performed in murine 
or human systems, but immune cells of other vertebrate species appear to 
respond similarly to CpG DNA although the specific sequence requirements 
for optimal stimulation vary (Mutwiri et al., 2003). Porcine PBMC respond 
to class A ODNs with high IFN-α production, and the induction is 
dependent on a central unmethylated CpG motif. (Domeika et al., 2004; 
Guzylack-Piriou et al., 2004; Kamstrup et al., 2001). Class A ODNs with 
chimeric PO/PS-backbone are strong inducers, but also solely PO-ODNs 
can induce high levels of IFN-α in porcine PBMC, although the PO-
ODNs generally require pre-treatment with a transfecting agent such as 
Lipofectin (Domeika et al., 2004). The IFN-α inducing capacity of 
PO-ODNs has been demonstrated to increase by the hybridization of two 
complementary ODNs to a double-stranded ODN, and the addition of 
poly-guanosine (Poly-G) sequences at the 5´ and 3´ ends further enhanced 
the IFN-α production (Domeika et al., 2004). In addition to IFN-α, class A 
ODNs induce the production of TNF-α and IL-12 by porcine PBMC 
(Guzylack-Piriou et al., 2004; Kamstrup et al., 2001). Within the porcine 
PBMC, the cell population responsible for the IFN-α production in 
response to stimulation with type A ODNs has been identified as the 
PDC/NIPC (Domeika et al., 2004; Guzylack-Piriou et al., 2004), in 
accordance with results from studies in human and murine systems. 
Recognition of immunomodulatory DNA 
Toll-like receptors 
TLRs are evolutionary conserved PRRs of the innate immune system that 
recognize pathogen-associated molecular patterns (PAMPs) expressed by 
microorganisms. These PAMPs are common for many microbes and include 
cell wall components and ss or ds nucleic acids. Binding of ligands to the 
TLR triggers a series of signaling events resulting in a fast innate response 
facilitating the elimination of the pathogen. The expression, signaling and 
function of TLRs have been subject to a large number of detailed studies, 
and a general summary of the current views in relation to the work of this 
thesis will be given here (reviewed by Chen et al., 2007; García-Sastre and 
Biron 2006; Ishii and Akira 2006; Kawai and Akira 2006). 
There are until date 13 different TLRs identified in mammals, of which 
TLR3, 7, 8 and 9 are so far thought to be of importance in the defense 
against viral infections. TLR3 recognizes dsRNA and TLR7 ssRNA of viral 26 
or synthetic origin (Table 1). The ligand for TLR9 is unmethylated CpG 
DNA. TLR3, 7, 8 and 9 are normally not expressed on the surface of 
immune cells, but are found in the endosomal compartment where the 
probability for interaction with their ligands is increased. TLR9 is expressed 
within the endoplasmatic reticulum (ER) of B  cells and PDC and is 
translocated to endosomal compartments upon stimulation. Extracellular 
CpG DNA binds to the cell surface and is translocated into early endosomes 
through clathrin-dependent endocytosis (Ishii and Akira 2006). The 
internalization of TLR ligands into endosomes can also be facilitated trough 
other pathways involving Fc receptors and scavenger receptors, increasing 
the possibility of interaction between ligand and receptor. The early 
endosome then mature into a late endosome resulting in a drop of pH. 
Interaction between TLR9 and CpG DNA initiates a complex signaling 
pathway involving numerous signaling proteins including the adaptor 
molecule myeloid differentiation primary response protein 88 (MyD88), that 
activate transcription factors such as nuclear factor (NF) κB, IFN regulatory 
factors (IRF) 5 and 7 and activating protein 1 (AP-1), ultimately resulting in 
the production of type I IFNs and other proinflammatory cytokines (García-
Sastre and Biron 2006; Kawai and Akira 2006) (Fig. 3). 
Non-CpG ligands of TLR9 and alternative receptors for nucleic acids 
Although it is well established that CpG DNA is the ligand for TLR9, other 
non-CpG structures interacting with TLR9 have also been identified. 
PS-ODNs without CpG dinucleotides can activate the innate immunity in a 
TLR9-dependent manner, and the heme metabolite hemozoin that is 
generated during malarial infection of erythrocytes has been shown to 
interact with TLR9. Until recently, TLR9 was the only identified cellular 
receptor that recognized DNA, although several studies have reported 
TLR9-independent stimulation of type I IFN by dsDNA accumulated in 
the cytoplasm (Takaoka and Taniguchi 2007). One cytosolic receptor for 
dsDNA has been identified and is referred to as the Z-DNA binding protein 
1 (ZBP-1) or DNA-dependent activator of IFN-regulatory factors (DAI) 
(Wang et al., 2008; Takaoka et al., 2007). This receptor was reported to 
bind DNA and subsequently activate transcription of type I IFNs, but 
detailed information is until date lacking and further characterization of its 
function and signaling process is required. In addition to DAI, there are also 
indications of other until date unknown cytosolic receptors for DNA (Wang 
et al., 2008). Cytosolic receptors sensing RNA primarily originating from 
viral infections have been identified. Among these, retinoic acid inducible 
gene (RIG)-I-like proteins and cytosolic receptor melanoma differentiation-  27 
associated gene-5 (MDA5) are best characterized (Takeuchi and Akira 2008; 
Kawai and Akira 2006). 
 
Table 1. Summary of PRRs of importance for the recognition of nucleic acids and their expression and 
subcellular localization in human immune cells.  
Receptor Cell  expression Localization  Ligand  Origin 
TLR3
1  Myeloid DC  Endosome?  dsRNA  Virus,            
Poly I:C 
TLR7
1, 2  Monocytes*  
Myeloid DC*      
PDC 
B cells 
Endosome  ssRNA  Virus,             
Synthetic compounds 
TLR8
1 
 
Monocytes  
Myeloid DC 
Endosome  ssRNA  Virus,            
Synthetic compounds 
TLR9
1, 2  PDC                
B cells 
Endosome  CpG DNA  Virus, bacteria and 
parasites,       
Synthetic ODNs 
RIG-I ?  Cytoplasm  dsRNA  Virus 
MDA5  ?  Cytoplasm  dsRNA  Virus,             
Poly I:C 
DAI  ?  Cytoplasm  dsDNA  Virus and bacteria       
      Synthetic  compounds? 
References: 1: Iwasaki and Medzhitov 2004; 2: Hornung et al., 2002  
*reported in some studies but not in others. 
 
ODN structure and intracellular processing 
Following interaction with TLR9 and the initiation of the signaling cascade, 
CpG DNA can elicit powerful responses in immune cells. Specific responses 
by CpG DNA have been studied using synthetic ODNs and the type of 
immune response can be more or less tailor made depending on the 
physicochemical characteristics of the ODN. The difference in effect of class 
A and B ODNs has been suggested to result from alternative intracellular 
compartmentalization of the ODNs. The robust IFN-α  production   
induced by class A ODNs has been demonstrated to be dependent on 
prolonged retention in early endosomes of PDC (Honda et al., 2005). The 
mechanism responsible for ODN uptake and processing of CpG DNA is far 
from clarified, but the scavenger receptor CXCL16 expressed on PDC has 
been observed to be responsible for uptake and trafficking of A-class but not 
B-class ODNs to early endosomes (Gursel et al., 2006). 28 
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Figure 3. Schematic overview of the current general view of cellular uptake and processing of 
CpG DNA in PDC and the signaling through TLR9. Extracellular CpG DNA is bound by 
membrane receptors such as scavenger receptors and other until date unidentified receptors. 
The receptor-DNA complex is internalized through clathrin-dependent endocytosis into 
early endosomes. Upon stimulation, TLR9 is translocated from the rough endoplasmatic 
reticulum to the early endosomes where it associates with CpG DNA. The early endosome 
matures into a late endosome and the resulting acidification initiates signaling through TLR9. 
The signaling cascade involves numerous substances including the adaptor molecule MyD88 
and results in the activation of transcription factors such as IRF-5, 7, AP-1 and NFκB. The 
transcription factors are translocated to the nucleus where transcription of genes for type I 
IFN and other pro-inflammatory cytokines is initiated.   29 
In addition, the secondary structure of A-class ODNs is of major 
importance for their IFN-α inducing capacity whereas B-class ODNs 
primarily are active as linear monomers (Ishii and Akira 2007; Kerkmann et 
al., 2005; Wu et al., 2005). The A-class ODNs assemble spontaneously to 
multimeric forms due to the central palindromic sequences and the presence 
of poly-G sequences enable tertiary structures through G-tetrad formation 
(Kerkmann et al., 2005). 
Inhibitory DNA motifs 
Although most of the data generated on CpG DNA concerns the 
immunostimulatory capacity, there is an increasing interest for inhibitory 
CpG motifs. There are several reports of various inhibitory effects of ODNs 
bearing different characteristics, and in an attempt to confer an overview of 
the data, Trieu et al. proposed a categorization of inhibitory ODNs into 
four groups based on sequence and probable mode of action (Trieu et al., 
2006). 
Class I inhibitory ODNs are G-rich ODNs that efficiently inhibit all 
tested responses to CpG DNA, both class A and B. There is evidence for 
specific sequence requirements, but secondary structure seems to be of 
importance only in the inhibition in PDC and not in B cells. Most of the 
class I ODNs tested have been PS-modified, but PO-ODNs are also 
inhibitory although they require higher concentrations probably due to less 
efficient cellular uptake than PS-ODNs. The exact mechanism by which 
class I ODNs act has not been identified, but competition in direct binding 
to TLR9 has been suggested as a more probable mode of action than 
inhibition of cellular binding and uptake of CpG ODNs. 
Class II inhibitory ODNs contain telomeric repeats with the TTAGGG 
hexamer that are naturally present in mammalian but not microbial DNA. It 
has been suggested that recognition of methylated telomeric repeats prevents 
activation of TLR9 by self-DNA. The telomeric repeats are thought to 
inhibit signaling through signal transducer and activator of transcription 
(STAT) in response to autocrine and paracrine IFN-α, IFN-γ and IL-12 
induced by CpG DNA and is therefore independent of TLR9. 
Class III inhibitory ODNs (Oligo dG) consist of long, vertebrate dsDNA 
molecules that are thought to inhibit the cellular uptake of DNA by 
saturation of receptors. Long dsDNA bind scavenger receptors and other 
unknown molecules and is taken up more efficiently than CpG DNA and 
bacterial DNA. Long dsDNA is, however, not taken up in B cells, and is 
consequently not an efficient inhibitor in these cells. 30 
Class IV inhibitory ODNs contain long PS-ODNs that are thought to 
bind to TLR9 with higher affinity than shorter ODNs. These ODNs are 
less sequence specific than shorter ODNs, and the inhibitory activity is 
thought to be mediated through competition of binding to TLR9. 
Plasmacytoid dendritic cells 
The plasmacytoid dendritic cells (PDC) or natural IFN producing cells 
(NIPC) are characterized by their extraordinary capacity to produce type I 
IFNs in response to stimuli by viral, bacterial and synthetic agonists to 
TLR7 and 9. The ability to sense and rapidly react to microorganisms in 
combination with modulatory effects on other parts of the immune system 
following activation makes the PDC key players on the interface between 
the innate and adaptive immunity. There are vast numbers of publications 
on PDC and their function, and the following sections will therefore focus 
on the current views regarding the areas of relevance for the work of this 
thesis (reviewed by Fitzgerald-Bocarsly et al., 2008). 
Phenotype and function of PDC 
The PDC can internalize and react to microbial products due to the 
expression of PRRs such as TLR7 and 9 as well as C-type lectin receptors, 
scavenger receptors and chemokine receptors. In addition, the presence of 
FcγRII (CD32) enables the PDC to internalize antigen opsonized by bound 
immunoglobulin (Ig) G-antibodies (Fitzgerald-Bocarsly et al., 2008; Gursel 
et al., 2006). Characteristically, human PDC express several surface markers 
including CD4 and MHCII but do not express lineage markers for T cells 
(CD3), B  cells (CD19), NK  cells (CD56, CD16) or monocytes (CD14) 
(Fitzgerald-Bocarsly et al., 2008; Svensson et al., 1996). Following activation 
the PDC mature and change characteristics from IFN-producing cells to 
antigen presenting cells (APC) resulting in increased expression of MHCII 
and costimulatory molecules (CD80/86, CD40). As APC, the PDC can not 
only activate CD4
+ Th cells through presentation on MHCII, but also CD8
+ 
cytotoxic T  lymphocytes (CTL) through cross-presentation on MHCI 
(Fitzgerald-Bocarsly et al., 2008). 
In addition to type I IFN, PDC produce the pro-inflammatory cytokines 
TNF-α and IL-6 as well as chemokines, although at markedly lower levels. 
TNF-α drives the differentiation of PDC to antigen presenting cells and 
IL-6 in combination with IFN-α promotes the differentiation of antibody-
secreting plasma cells. Murine and porcine, but not human PDC also 
produce IL-12 upon stimulation (Fitzgerald-Bocarsly et al., 2008; Guzylack-  31 
Piriou et al., 2004). The chemokines produced by PDC selectively recruit 
NK  cells and activated T  cells facilitating an efficient immune response 
against viral infections. 
Functions of type I IFNs 
Type I IFNs have many important and complex effects on a wide range of 
immune functions including antiviral defense, regulation of cell growth and 
apoptosis as well as immunomodulation. Signaling through the type I IFN 
receptor (IFNAR) results in alterations of the expression of hundreds of 
genes (Theofilopoulos et al., 2005). An immediate effect of IFN-α secreted 
by a virus-infected cell is the mediation of an antiviral state in neighboring 
cells preventing spread of the infection (García-Sastre and Biron 2006). 
IFN-α/β mediates apoptosis of virus-infected and tumor cells and have anti-
proliferative effects by inhibiting cell cycle progression into S phase 
(Chawla-Sarkar et al., 2003; Samuel 2001). In contrast, the presence of 
IFN-α increases the survival and maturation of PDC into APC that 
subsequently activate naïve T cells. In addition, IFN-α is of vital importance 
for the ability of PDC to cross-present antigens to CTL (Fitzgerald-Bocarsly 
and Feng 2007). IFN-α also promotes the survival of Th cells and CTL and 
stimulates NK-cell cytotoxicity and activation as well as differentiation of 
monocytes into macrophages. The activation of Th and NK cells stimulates 
the production of IFN-γ as well as the upregulation of IL-12 receptor in 
these cells resulting in a strong Th1 profile of the immune response.  
Type I IFN does not, however, solely act on the cellular immunity, but 
also affect the humoral immunity by stimulating antibody responses and Ig 
isotype switching. In addition, IFN-α/β promote survival of B  cells and 
differentiation of activated B  cells into plasmablasts and Ig-secreting 
plasmacells in the presence of IL-6 (Theofilopoulos et al., 2005). 
In conclusion, the activation of PDC by PAMPs can induce a robust 
production of type I IFNs resulting in not only a strong Th1 immune 
response with efficient cellular immunity, but also a stimulation of humoral 
responses. 
Porcine PDC 
Porcine NIPC were first identified as non-adherent, non-T, non-B cells that 
were efficient producers of IFN-α in response to infection with the corona 
virus transmissible gastroenteritis virus (TGEV) or the herpes virus ADV 
(Artursson et al., 1995; Nowacki and Charley 1993; Charley and Lavenant 
1990). Porcine PDC constitute a small population, commonly ranging only 
between 0.1 and 0.3% of the total PBMC (Domeika et al., 2004; 32 
Summerfield et al., 2003), and the cells share many characteristics with their 
human counterpart. Phenotyping of the expression of cell-surface markers 
have identified the porcine PDC among cells expressing the myeloid marker 
swine workshop cluster (SWC) 3 (also denoted CD172a) as CD4
+, CD14
- in 
contrast to the conventional myeloid DC that are CD4
-, CD14
-, or 
monocyte-derived DC expressing CD14 but not CD4 (Domeika et al., 
2004; Summerfield et al., 2003). During stimulation of porcine cells with 
bacterial and viral components as well as ODNs, the PDC have been 
identified as responsible for the rapidly increased levels of IFN-α in the cell 
cultures (Domeika et al., 2004; Guzylack-Piriou et al., 2004). 
PCV2, PDC and immunomodulatory DNA 
PCV2 can be detected in porcine PDC, and the apparently silent infection 
has been suggested to provide a vehicle for dissemination of PCV2 
throughout the body of the host (Vincent et al., 2003). Due to the central 
role of PDC in the initiation and direction of immune response, the 
interaction with PCV2 may be a crucial event during infection and 
development of disease. PDC infected with PCV2 respond to stimulation 
with CpG ODNs and viral infections with impaired production of IFN-α 
and TNF-α (Vincent et al., 2005; Vincent et al., 2003). Viruses have 
developed several sophisticated counter measures to evade the 
IFN-α-response of the host upon infection (García-Sastre and Biron 2006), 
and immunomodulatory activity of viral DNA has been described for 
adenovirus and herpes simplex virus (Krieg et al., 1998; Lundberg et al., 
2003). The work of this thesis focuses on the interaction between PCV2 and 
the porcine immune system, and specifically on the presence of potentially 
immunomodulatory sequences within the genome of PCV2. 
   33 
Aims of the present study 
The general objective of this thesis was to increase the understanding of the 
complex interaction between PCV2 and the immune system of the pig. This 
includes the disease mechanisms during clinical PMWS as well as the 
underlying mechanisms of the persistent infection of subclinically infected 
pigs. 
 
More specifically, the aims of the studies included in this thesis were; 
  to study the development of immune response parameters and 
clinical disease in pigs experimentally infected with PCV2 (I, II); 
  to elucidate possible differences in pathogenicity between isolates of 
PCV2 originating from farms with or without clinical PMWS in 
experimentally infected pigs (I); 
  to evaluate the effect of postweaning colibacillosis on the 
development of PMWS in colostrum-fed pigs experimentally 
infected with PCV2 (II); 
  to study the presence of potentially immunomodulatory DNA 
sequences within the genome of PCV2 with special reference to 
IFN-α production by porcine PBMC in vitro (III-V); 
  to identify characteristics rendering ODNs immunomodulatory in 
porcine PBMC in vitro (III-V); 
  to expand the characterization of the effect of an inhibitory ODN 
to include the expression of various porcine cytokines in vitro (V).   34 
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Comments on Material and Methods 
In order to clarify the choice and use of materials and methods used in the 
studies of this thesis, a brief presentation is given here. Additional details are 
presented in the material and methods sections of the individual papers. 
Experimental infections 
In paper I, the model for experimental reproduction of PMWS in young 
pigs was transferred from the group of Dr Gordon Allan, Virology Branch, 
Queen’s University of Belfast. The study was performed in order to 
elucidate potential differences between two isolates of PCV2; Imp  1010 
Stoon (GenBank accession no. AF055392), isolated from the first cases of 
PMWS in Saskatoon, Canada, and a Swedish PCV2 isolated from material 
collected in 1993 from a clinically healthy SPF-pig (ORF2 sequence; 
GenBank accession no. EF184220). In brief, snatched-farrowed colostrum 
deprived (SFCD) or caesarean-derived colostrum-deprived (CDCD) pigs 
were used in order to guarantee the sero-negative status of the animals prior 
to PCV2 infection. The litters were split into five experimental groups that 
received an intranasal challenge on the third day of life; 1) uninfected 
control (mock); 2) control infected with PPV alone; 3) PCV2 (Imp. 1010 
Stoon) in combination with PPV; 4) PCV2 (Swedish isolate) in combination 
with PPV and 5) PCV2 (Swedish isolate) in combination with PPV (in 
Denmark). 
Throughout the study the pigs were observed for clinical signs of disease, 
and blood samples were collected on days 0, 8, 15, 22 and 28 (groups 1-4) 
or 4, 7, 14, 21 and 27 (group 5) post infection (DPI). Four weeks post 
infection, all remaining pigs were sacrificed and necropsied. Gross and 
histopathological lesions were recorded, and immunohistochemistry for the 
detection of PCV2 antigen was performed on cryostat sections using a 36 
PCV2 polyclonal antibody as previously described (Ellis et al., 1998). Levels 
of antibodies to PCV2 in serum was quantified in an immunoperoxidase 
monolayer assay (IPMA) as previously described (Ladekjær-Mikkelsen et al., 
2002; Allan et al., 2000b). Antibodies to PPV were detected by ELISA 
(Svanovir PPV-Ab, Svanova Biotech, Uppsala, Sweden). Levels of PCV2 
DNA in serum from the pigs in group 5 were quantified using a real-time 
PCR protocol described elsewhere (Ladekjær-Mikkelsen et al., 2002). IL-10 
was detected in sera from pigs in groups 1-4 by ELISA (Biosource, 
Camarillo, CA) and IFN-α was quantified by a dissociation-enhanced 
fluoro-immuno assay (DELFIA) as described below. 
In paper II a modified model for the provocation of postweaning 
colibacillosis (Melin et al., 2004; Melin and Wallgren 2002) was used in 
combination with inoculation with PCV2. Healthy, colostrum-fed, four-
week old SPF-pigs were used in the study in order to simulate the natural 
conditions on farms. In brief, 28-day-old pigs originating from four litters 
were transported to the animal facilities at the National Veterinary Institute 
and were divided into two groups (control group pig nos. 1-8; challenged 
group pig nos. 9-16) housed separately. Pigs in the challenged group were 
exposed to pathogenic strains of E. coli spread onto the pen floor at days 0 
(day of arrival), 7 and 14, and were inoculated intranasally with PCV2 
(Swedish isolate as used in the previous study) at day 10. Pigs in the control 
group were only inoculated intranasally with an uninfected cell lysate at day 
10. A summary of the inoculations is given in Table 2. 
Blood samples were collected at days 0, 1 and 3 and thereafter twice a 
week. Fecal swabs were collected twice a week to determine the excretion 
of the challenge strains of E. coli. Health status of all pigs was recorded every 
day and each individual was weighed and the inguinal lymph nodes were 
palpated twice a week. The trial was terminated at day 49 when all pigs 
were sacrificed and necropsied. Tissue samples were collected for 
histopathological examination, and the weight of one inguinal lymph node 
from each pig was determined. Presence of PCV2 antigen in tissues was 
determined by immunohistochemistry and levels PCV2 antibodies in serum 
were measured as described above. PBMC were isolated and functional tests 
measuring proliferation and IFN-α production were performed as described 
below. The presence of PCV2 DNA in sera and PBMC was determined 
using a quantitative real-time PCR assay. 
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Table 2. Summary of infectious challenges with E. coli and PCV2 in the experimental 
model used in paper II. 
   Challenge   
Group  Day 0  Day 7  Day 10  Day 14 
Challenge  E. coli O149  E. coli O141  S-PCV2   E. coli O141 
Control _  _  Uninfected 
cell lysate 
_ 
Isolation of peripheral blood mononuclear cells 
Heparinized blood samples were collected from vena cava cranialis and 
PBMC were separated from plasma, neutrophils and erythrocytes by 
density-gradient centrifugation on Ficoll-Paque (Pharmacia, Uppsala, 
Sweden) for 40  minutes at 500  x  g. The band containing PBMC was 
collected, and following two washes in phosphate buffered saline (PBS), the 
cells were dispensed in complete medium (RPMI 1640 supplemented with 
20 mM HEPES buffer, 2 mM L-glutamine, 200 IU penicillin/ml, 10 µg/ml 
streptomycin 0.5 µM 2-mercaptoethanol and 5% fetal calf serum) at a final 
concentration of 5 x 10
6 cells/ml. 
Inducers of IFN-α 
ODNs were purchased desalted and dissolved in water (Cybergene, 
Huddinge, Sweden) and stored in aliquots at -80
oC until further use. The 
plasmid pcDNA3 was purified using the EndoFree Plasmid Maxi kit 
(Qiagen, Hilden, Germany) and passed over a Detoxi-Gel column (Pierce, 
Rockford, IL) in order to minimize the endotoxin content. ODNs and 
plasmid preparations were tested for endotoxin content using the limulus 
amebocyte lysate test (QCL-1000 test, BioWhittaker East Rutherford, NJ), 
and only preparations containing less than 0.25 EU endotoxin per ml were 
used in subsequent induction studies. ADV (strain Bartha) was inactivated by 
four cycles of UV-irradiation (1 Joule/cm
2). Polyriboinosinic-
polyribocytidylic acid (Poly  I:C) was dissolved in saline according to the 
manufacturer’s instructions and was stored at +4
oC. Sendai virus (SV) was 
propagated in eggs and the chorioallantoic fluid was collected and stored at 
–80
oC. Where indicated, the inducer was pre-incubated with the transfecting 
agent Lipofectin (Invitrogen Life technologies, Carlsbad, CA) prior to 
addition to cell cultures. 38 
Table 3. Nucleotide sequence, concentrations and requirement for pre-treatment with Lipofectin of 
ODNs and other inducers used in cultures of porcine PBMC. PO-nucleotides in upper case, PS in 
lower case. C
M represents methylated cytosine 
Inducer  ODN sequence 5´ -3´  Conc   Lipo  Paper 
PCV2/1 CCCCCCTCCCGGGGGAACAA  25 µg/ml    III, IV, V 
PCV2/2 ACTTCGGCAGCGGCAGCACC  25 µg/ml  +  III 
PCV2/3 ACCCTGTAACGTTTGTCAGA  25 µg/ml  +  III 
PCV2/4 CTGTGTGATCGATATCCATT  25 µg/ml  +  III 
PCV2/5 GTTTTCGAACGCAGCGCCGA  25 µg/ml  +  III 
PCV2/1C TTGTTCCCCCGGGAGGGGGG  25 µg/ml    III 
PCV2/1
met  CCCCCCTCCC
MGGGGGAACAA  25 µg/ml    IV 
PCV2/1a CCCCCCTCCCAAAGGAACAA  25 µg/ml    IV 
PCV2/1b CCCCCCTAAAGGGGGAACAA  25 µg/ml    IV 
PCV2/1c CCCCCCTAACGAAGGAACAA  25 µg/ml    IV 
PCV2/1d CAACCATCCCGGGGGAACAA  25 µg/ml    V 
2216 ggGGGACGATCGTCgggggG  5 µg/ml    III, IV, V 
D19 ggTGCATCGATGCAGggggg  25 µg/ml    III 
D25 GGTGCATCGATGCAGGGGGG  25 µg/ml    III 
IRS 869  tcctggaggggttgt  5, 10, 25 µg/ml ?  V 
H TTTTCAATTCGAAGATGAAT  25 µg/ml  +  III, IV 
I ATTCATCTTCGAATTGAAAA  25 µg/ml  +  III, IV 
H1a GGTATTTCGAAATAGGGGGG  25 µg/ml    IV 
H1a
met  GGTATTTC
MGAAATAGGGGGG  25 µg/ml    IV 
H1b GGGGGGTATTTCGAAATAGG  25 µg/ml    IV 
H1c GGGGGGTATTTCGAAATAGGGGGG  25 µg/ml  +  IV 
H2a GGTTCGAAGGGGGG  25 µg/ml  +  IV 
H2b GGGGGGTTCGAAGG  25 µg/ml  +  IV 
H2c GGGGGGTTCGAAGGGGGG  25 µg/ml    IV 
H3b GGGGGGTATTTCGAATAAGG  25 µg/ml  +  IV 
H3c GGGGGGTATTTCGAATAAGGGGGG  25 µg/ml    IV 
H
Poly-G  TTTTCAATTCGAAGATGAATGGGGG  25 µg/ml  +  III 
H
G-tail 2  GGTTCAATTCGAAGGGGGGG  25 µg/ml  +  IV 
I
G-tail 2  GGTTCGAATTGAAGGGGGGG  25 µg/ml  +  IV 
pcDNA3   2.5  µg/ml  +  III, IV 
ADV   10
5TCID50 1:100   III, IV 
SV   1:10    III, IV 
Poly I:C   5  µg/ml  +  III, IV, V 
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Lipofectin was used at a final concentration of 2.5 µg/ml. A summary of 
inducers, ODN sequences and final concentrations used in cell cultures is 
given in Table 3. References to the origin of each ODN used is presented 
in the material sections of the papers. 
Hybridization and denaturation of ODNs 
Single stranded ODNs with complementary nucleotide sequences 
(H
G-tail2-I
G-tail2, PCV2/1-PCV2/1C) were hybridized to form double stranded 
molecules by heating equimolar amounts of the ODNs to 95
oC for 5 
minutes followed by slow cooling to room temperature and additional 30 
minutes incubation at room temperature. Denaturation of the spontaneously 
formed secondary structure of ODN 2216 was performed by heating to 
100
oC for 5 minutes followed by rapid cooling and subsequent storage on 
ice until further use in cell cultures. 
Prediction of secondary structures of ODNs 
The theoretically most probable secondary structures of the ODNs were 
predicted using the IDT SciTools Oligo Analyzer 3.0 software. The 
spontaneous self-dimer formations and ds-formations following 
hybridization as well as spontaneous hair-pin structures with the lowest ΔG 
value (kcal/mol) were used since the variants requiring the least amount of 
energy are most probable to occur. 
Methylation of the PCV2 genome 
In order to elucidate the methylation status of the genome of PCV2, 
restriction enzyme analysis was performed using isoschizomeric pairs of 
restriction enzymes on a low molecular weight DNA extract. MspI and 
HpaII recognize the same sequence (CCGG), but HpaII cleavage is blocked 
if the cytosine in the CpG is methylated. DpnI and MboI recognize GATC, 
but DpnI requires methylation of the cleavage site whereas MboI digestion is 
blocked by methylation. EcoRI was included to provide a linearized control 
size reference. Following digestion, the fragments were separated on an 
agarose gel and subsequently visualized by Southern blot.  
Functional tests of PBMC 
Proliferation assay and viability of PBMC 
PBMC were isolated from pigs in paper II as described above and cultured 
in microtiter plates at 5x10
6 cells/ml in triplicate cultures with plain growth 40 
medium or in the presence of pcDNA3. After 20 hours of incubation the 
supernatant was collected from each well and stored at –20
oC until further 
analysis of IFN-α content. Plain growth medium was added to the cultures 
and the plate was incubated for another 48 hours when 
3H-thymidine was 
added. Following 24 hours of incubation (total incubation time 94 hours) 
the cultures were harvested onto nitrocellulose filters and the radioactivity 
incorporated at cell division (cpm value) was measured in a liquid 
scintillation counter (Betaplate counter; LKB Wallac, Turku, Finland) and 
used as an estimate of cell proliferation. 
Viable PBMC in cultures with ODNs were detected by flow cytometry 
as Annexin V and Propidium Iodide (PI) double negative cells. Annexin V 
binds phosphatidylserine exposed in the cell membrane of apoptotic cells. PI 
binds to chromatin but can only enter cells with damaged cell membranes 
such as necrotic or late apoptotic cells. Staining and detection was performed 
as previously described (Båve et al., 2000). 
Detection of IFN-α and IFN-α-producing cells 
Levels of IFN-α secreted in cell culture supernatants were determined using 
a dissociation-enhanced lanthanide fluoro-immunoassay (DELFIA) based on 
two monoclonal antibodies to porcine IFN-α (F17 and K9 kindly provided 
by Bernard Charley, Jouy-en-Josas, France). The quantification of IFN-α 
(units (U)/ml) was made by comparison to a laboratory standard of natural 
porcine IFN-α (Artursson et al., 1995). DELFIA has a wider range for 
detection of IFN-α (0.3–800 U) compared to ELISA (0.5-50 U) based on 
the same mAbs (Diaz de Arce et al., 1992). IFN-α-producing cells were 
detected and enumerated by enzyme-linked immunospot (ELISPOT) assay 
based on the same two monoclonal antibodies to IFN-α as used in the 
DELFIA. 
Extraction of RNA and cDNA synthesis 
Total RNA was isolated from cultured cells after 6 or 20 hours of 
incubation by combining the recommended protocols for Trizol reagent 
(Invitrogen, Carlsbad, CA) and the RNeasy Mini kit (Qiagen, Hilden, 
Germany). In brief, following phase separation in the Trizol reagent 
protocol the RNA-containing aqueous phase was mixed with an equal 
amount of 70% ethanol and transferred to an RNeasy Mini kit spin column 
for RNA purificiation. The quantity and quality of the RNA was 
determined by spectrophotometry (NanoDrop ND-1000, NanoDrop 
Technologies, Montchamin, DE) at OD 260nm and OD ratio 260/280 nm   41 
respectively. Since the IFN-α gene is intronless, the isolated RNA was 
treated with DNase (Promega, Madison, WI) with an extended incubation 
time of 30 minutes in order to eliminate contaminating genomic DNA. First 
strand cDNA was synthesized using 1-2  µg of RNA as template and 
SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA). Control 
reactions for detection of contaminating genomic DNA were set up in an 
identical manner except for the exclusion of reverse transcriptase enzyme. 
These preparations were annotated –RT and were included in PCR assays 
for type I IFNs. 
Detection and quantification of cytokine mRNA 
The expression of mRNA for porcine cytokines was monitored by semi-
quantitative reverse-transcriptase (RT) PCR and quantitative real-time 
PCR. Primers and probes for the detection of porcine IFN-α, IFN-β, 
IFN-γ, IL-1β, IL-6, IL-10, IL12p40, TGF-β, TNF-α and the housekeeping 
genes Cyclophilin A, GAPDH and HPRT are given in tables 2 and 3 in 
paper V. Total mRNA was collected after 6 and 20 hours of culture. In the 
first study using semi-quantitative PCR, PBMC from one pig (pig no. 3) 
were stimulated with ODN 2216 in the presence or absence of ODN 
PCV2/1. In order to confirm the data from the semi-quantitative PCR, 
quantitative real-time PCR analysis was performed on the samples. In 
addition, PBMC from two pigs (pig nos. 1 and 2) were stimulated by ODN 
2216 or Poly I:C in the presence or absence of ODN PCV2/1 and the 
relative expression of cytokine mRNA was determined by quantitative 
PCR. 
Determination of the relative expression of cytokine mRNA in relation 
to the housekeeping genes was performed by calculating the geometric 
mean according to Vandesompele et al (2002).   42 
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Results and Discussion 
The studies included in this thesis were conducted in order to elucidate the 
complex interaction between PCV2 and the porcine immune system during 
various phases of infection including during clinical expression of PMWS. 
For that purpose, pigs were experimentally infected with PCV2 for in vivo 
and ex vivo studies. In addition, in vitro studies were conducted using PBMC 
obtained from conventionally reared pigs exposed to synthetic analogs to 
parts of the genome of PCV2. 
Experimental infections 
An experimental infection was performed using an established model where 
three-day old SFCD piglets were simultaneously inoculated with PCV2 and 
PPV (paper I). At the time for the study, PMWS had not been diagnosed in 
Sweden, but an isolate of PCV2 collected from a healthy Swedish pig in 
1993 (S-PCV2) as well as a PCV2 isolate originating from one of the first 
outbreaks of PMWS in Canada in 1996 (PCV2-1010) were used. S-PCV2 
has until date not been associated with natural cases of PMWS at herd level 
in Sweden, but it has been used successfully to reproduce clinical PMWS in 
SFCD piglets in the same experimental model in Northern Ireland (Allan et 
al., 2003). In this study (paper I), four experimental groups were established 
in order to elucidate potential differences in pathogenicity between the 
isolates; group 1: uninfected control; group 2: PPV infected control; group 
3: PCV2-1010 and PPV; group 4: S-PCV2 and PPV. In addition, an 
identical experiment was conducted in parallel in Denmark (group 5) using 
S-PCV2 and PPV in CDCD pigs. 
In a second experimental infection, colostrum-fed weaned piglets were 
challenged with S-PCV2 and E. coli according to a model for reproduction 
of postweaning diarrhea (paper II). By using older, colostrum-fed animals 44 
the trial was set to mimic the conditions on the farm, and a possible role for 
postweaning colibacillosis in the development of PMWS was elucidated. 
The pigs originated from a high-health SPF-farm with no prior history of 
PMWS, but S-PCV2 has been present on the farm for a number of years. 
Clinical and pathological expression of disease 
Pigs in all groups infected with PCV2 and PPV (group nos. 3, 4, 5, paper I) 
developed clinical disease and typical gross and microscopic lesions of 
PMWS. From the material included in this study it was not possible to 
discern between the clinical expression of disease in the different groups, and 
no significant difference in pathogenicity between the PCV2-isolates could 
be seen. It could, however, be noted that among the pigs that were 
sacrificed prior to the termination of the trial, only the pigs in groups 4 and 
5 (S-PCV2) showed clinical signs consistent with PMWS. A PCR analysis 
that discriminates between the PCV2 isolates confirmed that no cross-
contamination had occurred between the groups. At necropsy, all pigs in 
group 3-5 displayed gross lesions consistent with PMWS such as 
lymphadenopathy, jaundice, pulmonary lesions and thymic atrophy. At 
histopathological examination the most common findings were depletion of 
lymphoid tissues and non suppurative hepatitis, myocarditis, 
peribronchiolitis and pyelitis. In addition, pigs in the control group that 
were inoculated with PPV only (group no. 2) displayed non suppurative 
hepatitis, myocarditis and interstitial pyelitis demonstrating the pathogenicity 
of this virus. The effect of the coinfection with PCV2 and PPV is likely to 
be one of the triggering factors that makes the disease model successful for 
the reproduction of clinical PMWS in young SFCD or CDCD pigs. 
 In contrast to these results, the colostrum-fed pigs infected with PCV2 
in combination with E. coli (paper II) only showed mild clinical signs of 
disease, and none of the animals died prior to the termination of the trial. 
No pig developed severe postweaning diarrhea, but mild diarrhea was 
recorded on occasional days among pigs in the challenged group. This was 
intended when the experimental infection was designed in order to ensure 
that the animals would not be so severely affected by the colibacillosis that 
they would have to be sacrificed. A severe diarrhea could also possibly affect 
the PCV2 infection in that the virus may be cleared rapidly through the 
gastrointestinal tract instead of establishing a productive infection. Pigs that 
were challenged with PCV2 and E. coli infections had a lower mean body 
weight than pigs in the control group at the end of the trial and especially 
three pigs were denoted as thin (nos. 9, 11 and 12). During periods of the 
trial, the daily weight gain (DWG) of the challenged pigs was lower than   45 
that of the control pigs. The difference in DWG was greatest at the end of 
the trial (day 35) when the challenge strains of E. coli could no longer be 
detected in faces indicating that this difference in weight could be an effect 
of the PCV2-infection. 
At necropsy and histopathological examination, none of the pigs 
challenged with PCV2 and E. coli displayed lesions consistent with PMWS, 
although PCV2 was detected by immunohistochemistry in several organs 
(paper II). During the trial, pigs in the challenged group had enlarged 
inguinal lymph nodes with the maximal size recorded at day 35. At 
necropsy, the inguinal lymph nodes collected from pigs in the challenged 
group were larger in relation to the body weight of the pig than those of the 
pigs in the control group, indicating mild lymphadenopathy. However, the 
absence of other pathological lesions at necropsy indicate a recovery from 
the infectious challenge.  
Humoral response to PCV2 and PPV 
All SFCD and CDCD pigs in the experimental infection (paper I) were 
seronegative to PCV2 and PPV at the start of the trial, and all pigs in the 
groups receiving PPV infection (group nos. 2-5) had developed antibodies 
to PPV at day 8. Antibodies to PCV2 on the other hand developed later and 
were not detected until two weeks after inoculation. In addition, pigs 
infected with S-PCV2 displayed somewhat lower titers and a delayed 
response compared to pigs infected with PCV2-1010. This indicated a 
difference in antibody response to the two isolates or may be related to a 
possible difference in sensitivity of the IPMA used to detect antibodies to 
PCV2. The IPMA used in this study was based on PCV2-1010. Sequence 
analysis have revealed that PCV2 isolates differ at positions within regions 
that have been identified as likely B-cell epitopes (Timmusk et al., 2008). 
Indeed, exchange of amino acids within B-cell epitopes of PCV2 could 
influence the results of antibody-based diagnostic methods.  
Of interest is that all pigs but one (D8, group 3, heart failure) that died or 
were euthanized during the trial had no or very low levels of antibodies to 
PCV2. In contrast, the development of antibodies to PPV in these animals 
did not seem affected. This indicates an impaired humoral response during 
PMWS, but it seems to be restricted to the antibody response to PCV2 
rather than a general deficiency. Other studies have reported impaired 
humoral immunity to PCV2 in PMWS affected pigs (Fort et al., 2007; 
Meerts et al., 2005; Bolin et al., 2001), but the effect of PCV2 infection on 
the humoral response to other concurrent infections is until date poorly 
understood.  46 
In addition, it could be noted that all pigs in groups 3 and 4 that died 
during the trial belonged to the same litter (D). This may indicate a litter 
effect although the material included in this study is too limited to allow 
such conclusions, and further trials specifically designed for this purpose are 
needed. 
The colostrum-fed pigs that were challenged with PCV2 and E. coli 
(paper II) originated from a herd with an active infection of PCV2. All 
animals were subsequently seropositive for PCV2 at the initiation of the 
experimental infection. During the trial, pigs in the control group had 
remaining low or declining titers of antibodies to PCV2 whereas the 
antibody levels to PCV2 increased in pigs in the challenged group following 
PCV2-inoculation. There was a clear litter-related variation in the pattern of 
antibody response to PCV2 (Figure 2, paper II). 
Viral load and in vitro functions of PBMC  
Using quantitative real-time PCR, the number of PCV2 genome copies in 
serum and PBMC from pigs infected with PCV2 and E. coli was determined 
(paper II). PCV2 DNA was only detected in serum from two pigs (nos. 11 
and 12). The PBMC from these pigs also contained PCV2 DNA, with the 
highest copy numbers detected two to three weeks post inoculation with 
PCV2. The increase in viral load coincided with alterations in the in vitro 
functions of these cells. PBMC from pig nos. 11 and 12 displayed lower 
proliferation and IFN-α production in response to stimulation with the 
plasmid pcDNA3 at the same time points as the highest copy numbers of 
PCV2 DNA were detected. This indicates a detrimental effect of PCV2 
infection of immune cells. Of particular interest was that both pig nos. 11 
and 12 had the lowest levels of antibodies to PCV2 at the start of the trial, 
indicating that they may have had an impaired protection against the PCV2-
infection. 
IFN-α and IL-10 in serum 
IFN-α was detected in serum from SFCD pigs in all groups tested (1-4), 
including the controls at 8 DPI (paper I). This could be related to umbilical 
infections resulting in peritonitis in some pigs, probably due to the 
sensitivity of the young animals to opportunistic pathogens. At 15 DPI, 
however, IFN-α could only be detected in pigs from groups 3 and 4, 
associated with the PCV2 infection. The levels were generally low, but the 
three pigs with most clearly increased IFN-α all belonged to group 4 
(S-PCV2).   47 
IL-10 was detected, although at low levels at 8 DPI in sera from pigs in 
all infected groups (2-4). This peak may be associated with the PPV-
infection, and could represent a necessary factor in this disease model to 
provoke PMWS. Elevated levels of IL-10 were detected at later sampling 
occasions only in PCV2-infected pigs. Other studies have reported a possible 
role for IL-10 during the development of PMWS. In experimentally 
infected pigs, elevated levels of IL-10 were detected in serum of pigs that 
subsequently developed clinical PMWS (Stevenson et al., 2006), and a 
correlation between viremia and increased expression of IL-10 during 
subclinical PCV2 infection has been reported (Darwich et al., 2008). In 
addition, increased expression of IL-10 mRNA has been detected in thymus 
in association with histopathological lesions (Darwich et al., 2003) and in 
PBMC (Sipos et al., 2004) of PMWS-affected pigs. These results together 
indicate that IL-10 is involved in the disease development during PMWS, 
but does not clearly define how. An early increase in IL-10 may predispose a 
PCV2-infected pig to develop PMWS under certain conditions, but it is not 
certain that this IL-10 production is induced by PCV2 but may instead 
result from another factor such as a coinfection.  
In general, the levels of IFN-α and IL-10 detected in the SFCD pigs 
were very low (paper I). This is to be expected from systemic responses and 
additional determination of the local expression of mRNA in tissues is 
desirable. It is probable that the expression of cytokine mRNA varies greatly 
over time and between tissues, and analysis of material collected at necropsy 
may provide information that does not reflect the early stage of infection. 
Due to the design of the study this was not possible during the experimental 
infection since the number of animals included was too limited to allow 
sacrificing of pigs prior to the termination of the experiment.  
 
In summary, the results from the experimental coinfection of CD pigs with 
PCV2 and PPV (paper I) show that the Swedish isolate of PCV2 indeed is 
pathogenic in the experimental model and that the clinical expression of 
disease was not significantly different from that of PCV2-1010. The results 
also indicate the importance of the development of an adequate antibody 
response to PCV2 upon infection in the disease process of PMWS. The 
absence of clinical manifestations of disease in the colostrum fed pigs 
infected with PCV2 and E. coli (paper II) indicate that postweaning 
colibacillosis may not be involved in PMWS outbreaks, at least not during 
the conditions set for this study. This is in agreement with another recently 
published study where experimental inoculation with LPS in combination 
with PCV2 in 7-day-old CDCD pigs failed to induce expression of clinical 48 
disease consistent with PMWS (Fernandes et al., 2007). The pigs used for 
the experimental coinfection with PCV2 and E. coli ma y a lso ha ve been 
protected from the PCV2 infection by the presence of PCV2-antibodies and 
their relatively high health status. Still, colibacillosis may contribute to 
PMWS outbreaks during other conditions as some of the necessary 
triggering stressors could have been absent during this experimental 
infection. 
Immunomodulatory sequences in the PCV2 genome 
The presence and characteristics of immunomodulatory sequences in the 
genome of PCV2 was studied in order to elucidate the interaction between 
the immune system of the host and the genome of PCV2 (papers III, IV, V). 
The sequences were synthesized as PO-ODNs and tested for their 
immunomodulatory activity in cultures of porcine PBMC.  
Identification of CpG motifs 
The genome of PCV2-1010 (stoon) was analyzed for the presence of 
potentially immunostimulatory or inhibitory sequences. Five 20  nt 
sequences containing sequences corresponding to previously known 
immuno-stimulatory ODNs (H and D19; Magnusson et al., 2001) or 
inhibitory motifs (CCG; Krieg et al., 1998) were selected (paper III). The 
nucleotide sequences were distributed over the whole circular genome and 
were designated ODNs PCV2/1-5 (Figure 4, table 3). ODN PCV2/1 was 
theoretically inhibitory due to the long stretch of cytosines adjacent to a 
CpG motif. ODN PCV2/2 contained two potentially inhibitory CCG 
sequences. This ODN also represented part of the origin of replication 
adjacent to the stem loop in the genome of PCV2. ODNs PCV2/3-5 all 
included central hexamers (AACGTT or ATCGAA) found in known 
immunostimulatory ODNs. 
In cultures of porcine PBMCs, the PO-ODNs PCV2/2 to 5 stimulated 
varying levels of IFN-α although only in the presence of Lipofectin. ODN 
PCV2/2 was the weakest inducer, but was not inhibitory as it was thought 
when it was selected from the genome. This may be due to sequence 
specific differences between species, CCG could be an inhibitory motif in 
mouse but not in pig. 
Inhibitory activity of ODN PCV2/1 
ODN PCV2/1 did not induce IFN-α in the initial screening and was tested 
further for inhibitory activity in cultures of PBMC where IFN-α production   49 
was induced by previously known inducers (paper III). When IFN-α was 
induced by other ODNs (2216, H, I, D25), ADV or plasmid DNA 
(pcDNA3), ODN PCV2/1 could inhibit the induction to a varying degree 
(papers III, IV, V). The ODNs and ADV were generally inhibited to a large 
extent whereas pcDNA3 was only partially inhibited. One exception was 
ODN D19 that was not affected by the presence of PCV2/1. This may be 
explained by the fact that ODN D19 is a chimeric class A ODN with partial 
PS-backbone and that it was used at a relatively high concentration in the 
cell cultures. ODN 2216 is a similar class A ODN, but since the optimal 
concentration for IFN-α production is five times lower than that of D19, 
PCV2/1 may still act inhibitory on induction by ODN 2216. The 
mentioned inducers are all composed of DNA, are likely to act trough 
TLR9 to induce IFN-α production. 
In contrast, when IFN-α production was stimulated by inducers 
consisting of RNA (Poly I:C, SV), ODN PCV2/1 had no detectable 
inhibitory effect (papers III, IV, V). In fact, it seemed to increase the IFN-α 
production additionally, although this was not always statistically significant 
(paper IV). 
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Figure 4. Localization of ODNs 1-5 within the PCV2 genome. ODNs PCV2/1 and 5 are 
located in ORF2 and ODNs 3 and 4 in ORF1. ODN PCV2/2 is part of the stem loop and 
the origin of replication. 
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ODN PCV2/1 could also inhibit the production of several other 
cytokines induced by ODN 2216 as determined by quantitative real-time 
PCR (paper V). The reduction in expressed mRNA was most clearly 
detected for IFN-α, IFN-γ, IL-12p40 and IL-1β  but  TNF-α, TGF-β  and 
IL-10 showed similar patterns although the levels of mRNA expression 
were low. No inhibitory effect was detected on expression of cytokine 
mRNA stimulated by Poly I:C. These results indicate a broad inhibitory 
activity of ODN PCV2/1 on immunostimulation induced via TLR9 
illustrated by ODN 2216.  
Secondary structure of ODN PCV2/1 
At the time for the detection of ODN PCV2/1 (paper III), the knowledge 
of inhibitory, or neutralizing, DNA motifs was limited and the identified 
ODNs were characterized by the presence of G-tetrads or repeated clusters 
of CG sequences (Pisetsky and Reich 2000; Stunz et al., 2000; Zhao et al., 
2000; Krieg et al., 1998). The effect of remodeling ODN PCV2/1 was 
therefore tested using various agents for IFN-α induction. The inhibitory 
capacity of ODN PCV2/1 was not dependent on the presence of an 
unmethylated CpG motif, and the effect was similar regardless of ss or ds 
(hybridized) form (papers III, IV). In contrast, the inhibitory activity was 
dependent on the intrinsic ability of the ODN to form secondary structures 
(papers IV, V). The poly-G sequence could theoretically base pair with the 
poly-C sequence at the 5´ end of the ODN enabling a hair-pin structure 
(paper IV: figure 1b). If this characteristic was removed by altering the base-
pairing sequence, the IFN-α inhibitory activity disappeared (papers IV, V). 
Furthermore, the presence of a poly-G sequence in ODN PCV2/1 was not 
required for the IFN-α-inhibitory activity (paper V). This indicates that 
PCV2/1 does not act through G-tetrads as has been suggested for other 
inhibitory PO-ODNs (Trieu et al., 2006) 
The requirement for secondary structure formation for the function of 
ODN PCV2/1 was illustrated further by studies of the corresponding ODN 
from the genome of PCV1 (data not shown). This ODN had several 
exchanges in nucleotide sequence and thus a reduced ability to form 
secondary structures. The IFN-α inhibitory effect of the PCV1 ODN was 
remarkably lower than that of ODN PCV2/1. Although these results do not 
necessarily reflect an actual effect in vivo, it is of interest to note that none of 
the five ODNs selected from the genome of PCV2 is represented identically 
in the genome of the apathogenic PCV1.   51 
Secondary structure of Class A ODNs 
Secondary structure formation is of importance for IFN-α stimulatory 
activity of class A ODNs (Kerkmann et al., 2005; Wu et al., 2005). The 
PO/PS chimeric ODN 2216 spontaneously forms nanoparticle structures by 
self-dimers of palindromic sequences and G-tetrad formation through 
hoogsteen base pairs between poly-G sequences. The IFN-α inducing 
activity of the ODN can be eliminated through denaturation that renders 
the ODN unable to form secondary structures, (Kerkmann et al., 2005). 
Similar characteristics have been observed in PO-ODNs that induce IFN-α 
production in porcine PBMC (Domeika et al., 2004; Magnusson et al., 
2001). ODN H and its complementary ODN I both induce IFN-α in the 
presence of Lipofectin, and the induction was enhanced when the two 
O D N s  w e r e  h y b r i d i z e d  t o  f o r m  a  d s  O D N .  I n  a d d i t i o n ,  w h e n  p o l y - G  
sequences were added to ODN H, the IFN-α production increased. All 
these inductions were, however, dependent on the presence of Lipofectin. 
In order to elucidate the importance of a central palindrome as well as 
poly-G sequences for the induction of IFN-α, variants of ODN H were 
designed (paper IV). The main objective was to determine whether the 
requirement for treatment with Lipofectin could be circumvented by 
allowing spontaneous nanoparticle formation of the ODN. The results from 
this study showed that some of the modified PO-ODNs were indeed able to 
induce IFN-α production in the absence of Lipofectin. This required a long 
palindromic sequence (12 nt) and a poly-G sequence at either the 5´ or 3´ 
end (ODNs H1a and H1b) (paper IV; figure 1a and table 2). One of the 
shorter ODNs (H2c) also induced IFN-α production without pre-treatment 
with Lipofectin, although at lower levels. In addition, when the previously 
tested ODN H
G-tail2 was hybridized with its complementary ODN I
G-tail2 to 
form an 11 nt long ds  ODN with 3´ poly-G sequences, the need for 
Lipofectin was circumvented. These data indicate that the ability to form 
multimeric particles through palindromic or complementary sequences and 
G-tetrad formation is of importance for the IFN-α inducing activity of 
PO-ODNs. This significance of multimeric forms could be related to the 
cellular uptake of ODNs through scavenger receptors. The scavenger 
receptor CXCL16 has been demonstrated to mediate the uptake of class A 
ODNs in PDC and subsequently direct the delivery to early endosomes 
ultimately resulting in IFN-α induction (Gursel et al., 2006). This effect was 
not observed for class B PS-ODNs that generally appear as linear monomers, 
indicating that the difference in activity between the ODN classes could be 
a result of their physical composition. 52 
Lipofectin is a cationic lipid that forms micelles incorporating ODNs and 
directs the delivery to endosomal compartments of cells. The enhancing 
effect on ODN activity by Lipofectin is probably due to facilitated cellular 
uptake and delivery to the appropriate cellular compartments as well as 
protection from nuclease activity (Honda et al., 2005; Gursel et al., 2001; 
Xu and Szoka 1996). This was demonstrated using ODN 2216 (paper IV). 
In its native form, 2216 induces high levels of IFN-α production in the 
absence of Lipofectin due to spontaneous nanoparticle formation, as 
described above. After denaturation, however, the IFN-α production was 
greatly reduced, but could be restored by the addition of Lipofectin, 
indicating that the multimeric structures formed by Lipofectin mimics the 
nanoparticles spontaneously formed by ODN 2216. 
In addition to the secondary structures, a central, unmethylated CpG 
motif was necessary to stimulate IFN-α production by the PO-ODNs 
(paper IV). Methylation of the cytosine in the CpG motif of ODN H1a 
(H1a
met) that was a strong IFN-α inducer both in the absence or presence of 
Lipofectin resulted in a total loss of IFN-α production. This further suggests 
that the ODNs stimulate IFN-α production through interaction with 
TLR9. 
Function of ODN PCV2/1 
The mode of action of inhibitory ODNs is not as clearly defined as that of 
stimulatory ODNs. The inhibition of IFN-α production by ODN PCV2/1 
was demonstrated to depend on the ability of the ODN to form secondary 
structures, but it was insensitive to the removal of the central CpG motif 
(paper IV). This indicates that PCV2/1 does not act through classical 
interaction with TLR9 as stimulatory CpG motifs do. Class I inhibitory 
ODNs have been suggested to exert their activity by direct competition of 
binding to TLR9 and a subsequent conformational change in the adaptor 
protein MyD88 resulting in interrupted signaling (Lenert et al., 2006). These 
studies were, however, conducted using linear PS-ODNs and does not 
explain the requirement for secondary structure of PO-ODN PCV2/1. In 
addition, PS-ODNs can bind unspecifically to TLR9 (Yasuda et al., 2006), 
and may thereby affect the function of the receptor. 
Although there was no need for an intact CpG dinucleotide, the 
inhibitory effect of ODN PCV2/1 is likely to be mediated via TLR9 or 
along the signaling pathways used by this receptor. This was indicated by the 
fact that PCV2/1 could only inhibit IFN-α production induced by various 
forms of DNA (ODNs, ADV and pcDNA3) but not RNA (Poly I:C and 
SV). The expression of TLRs differ among types of immune cells and to   53 
some extent between species. Studies in human cells conclude that TLR9 is 
expressed by PDC and B cells whereas TLR3 is expressed by myeloid DC. 
TLR7 is found in both PDC and myeloid DC as well as monocytes and 
macrophages (Table 1). Poly  I:C is a synthetic dsRNA ligand of TLR3 
whereas the ssRNA genome of SV can activate signaling through TLR7. 
Since the SV preparation used in these studies was live, ds replicative 
intermediates of the RNA genome may be present, enabling additional 
activation through TLR3 in myeloid DC. The infectivity of SV also enables 
the recognition of viral RNA by cytosolic receptors such as the RIG-I-like 
proteins. RIG-I signaling is mediated via IFN promoter stimulator (IPS)-1 
and ultimately results in the activation of NFκB, IRF-3 or IRF-7 with 
subsequent transcription of IFN-α/β mRNA (Kawai and Akira 2006; 
Meylan and Tschopp 2006).  
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Figure 5. Schematic illustration of the signaling pathways following activation of TLR7/9 or 
3. TLR7/9 signaling is mediated through the adaptor protein MyD88 whereas TLR3 
signaling is conducted through TRIF. The activation of IRF-3 is initiated by TLR3 signaling 
and primarily results in transcription of IFN-β mRNA whereas activation of IRF-7 induces 
transcription of both IFN-α/β mRNA. IRF-5 in combination with AP-1 and NFκB result 
in the production of proinflammatory cytokines. 54 
In analogy with this, the mediation of IFN-α secretion in response to Poly 
I:C has been demonstrated   not  to  depend  on recognition by TLR3 but 
rather by the cytosolic recepor MDA5 (Gitlin et al., 2006; Kato et al., 
2006). MDA5 is closely related to RIG-I and stimulation leads to activation 
of NFκB and IRFs indicating a common pathway (Meylan and Tschopp 
2006). The lack of inhibitory activity of PCV2/1 on Poly I:C and SV 
indicate that ODN PCV2/1 inhibit somewhere in the TLR signaling where 
the  pathways of  TLR7/9 and 3 donot intersect (illustrated in figure 5), or 
that the RNA-stimulators induce IFN-α production by alternate signaling 
pathways such as RIG-I and MDA5. The partial inhibition of IFN-α 
production induced by plasmid DNA (pcDNA3) was consistently observed 
(papers III, IV, V). This could, in analogy to SV and Poly I:C, be a result of 
additional mechanisms besides TLR9 for recognition of plasmid DNA such 
as cytosolic DNA-receptors like DAI. Indeed, TLR9-deficient mice have 
been reported to mount a Th1-biased immune response to plasmid DNA 
used as DNA vaccination against ADV although the presence of TLR9 
resulted in better immunity (Tudor et al., 2005). 
The ELISPOT assay of IFN-α producing cells presented further 
indications that ODN PCV2/1 acts inhibitory on TLR9-mediated IFN-α 
production (paper IV). The number of IFN-α producing cells in cultures 
induced with ODN 2216 and ADV corresponds to the low frequency of 
PDC in PBMC (less than 1%). Furthermore, the spots were large indicating 
vast amounts of IFN-α produced by each cell. In the presence of ODN 
PCV2/1, the number of IFN-α-producing cells was markedly reduced 
rather than the amount of IFN-α secreted by individual cells. In cultures 
stimulated by Poly  I:C on the other hand, numerous small spots were 
detected by ELISPOT indicating small amounts of IFN-α secreted by many 
cells. This is in agreement with other studies reporting induction of IFN-α 
by monocytes in response to RNA (Hansmann et al., 2008; Gobl et al., 
1988) although at much lower levels than that secreted by PDC. ODN 
PCV2/1 did not influence the appearance or number of spots induced by 
Poly I:C which was in agreement with the results from the induction studies 
presented here (papers III, IV). 
The persisting IFN-α production by PBMC stimulated by SV/Poly I:C 
in the presence of ODN PCV2/1 indicates that the IFN-α-inhibitory 
activity was not a result of toxic effect on the cells. Furthermore, cultures of 
PBMC stimulated by ODN 2216 in the presence or absence of PCV2/1 
showed no difference in labeling with Annexin V or Propidium Iodide 
compared to control cultures indicating no increase in apoptosis or necrosis 
due to the ODNs (paper IV).   55 
In addition to direct binding to TLR9, competition of cellular uptake 
may represent a mechanism by which ODN PCV2/1 inhibit IFN-α 
production stimulated by TLR9 agonists. ODN PCV2/1 was not 
dependent of pre-treatment with Lipofectin indicating formation of higher 
order structures that mediate cellular uptake in analogy to what has been 
described for stimulatory class A ODNs. An additional possible mechanism 
for competition of cellular uptake is binding of high-mobility group box 
(HMGB) 1 protein. HMGB1 is an abundant chromatin-binding protein 
expressed by most nucleated cells and the main function is believed to be 
regulation of transcription. It is primarily located in the cell nucleus but is 
released from cells undergoing necrosis as well as secreted actively following 
inflammatory stimulation. Recently, a role for HMGB1 in CpG DNA 
mediated activation of TLR9 was described (Ivanov et al 2007; Krieg 
2007b; Tian et al., 2007). According to these studies, extracellular HMGB1 
binds CpG ODNs, primarily class A, and accelerates the delivery of the 
ODN to early endosomes. Moreover, HMGB1 preassociates with TLR9 in 
the ER and mediates a rapid transfer to early endosomes upon stimulation 
where interaction between TLR9 and CpG DNA occurs. The presence of 
HMGB1 greatly enhanced the cytokine response stimulated by CpG ODNs, 
and although further studies are needed to understand this interaction, it 
opens for theoretical extrapolation to the function of inhibitory ODNs. If 
ODN PCV2/1 binds extracellular HMGB1 and thereby prevents 
stimulatory CpG DNA to associate with HMGB1, the stimulatory effect of 
TLR9 agonists may be reduced. 
Importance of immunomodulatory sequences in the PCV2 genome 
There is a complex interaction between PCV2 and its host leading to 
persistent infection as well as severe clinical disease, and many aspects of this 
are still unclear. Since the virion carries a very limited amount of 
information the presence of immunomodulatory sequences in the genome 
of PCV2 may be of importance to establish infection. Indeed, PCV2-
infection of porcine PDC in vitro have been reported to inhibit the 
production of IFN-α and TNF-α in response to CpG ODNs (Vincent et 
al., 2005), and further studies associated the inhibitory effect with the viral 
DNA component (Vincent et al., 2007). In a preliminary study, the overall 
IFN-α modulatory activity of the whole PCV2 genome was tested in 
cultures of PBMC, and a stimulatory effect was detected (paper IV). This is 
in contrast to the results of Vincent et al., but may be explained by the 
different DNA preparations used. In the study presented here, a low-
molecular weight DNA extract (Hirt) from PCV2-infected PK-15 cells was 56 
used whereas Vincent et al. amplified the PCV2 genome in plasmids. This 
could result in diverging methylation patterns of CpG motifs, and may 
thereby influence the net effect of immunomodulatory sequences in the 
genome. In addition to methylation, the overall effect of the PCV2 genome 
on immune cells can be influenced by the number of immunomodulatory 
sequences and their relative location and spacing. In the original screening of 
the PCV2 genome performed in paper III, CpG motifs were found evenly 
distributed in the genome. In contrast, in a recent publication surveying 
several gene sequences for immunoregulatory activity, inhibitory ODNs 
were overrepresented within ORF1 (Kekarainen et al., 2008). These authors 
also report immunomodulatory effects of the DNA rather than the capsid of 
PCV2 on recall antigen responses to ADV. 
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Conclusions 
  There was no significant difference in clinical expression of disease 
between pigs experimentally infected with the two PCV2 isolates 
1010 stoon and S-PCV2. S-PCV2 is clearly pathogenic during 
experimental conditions although it has not been associated with 
natural cases of PMWS on herd basis 
 
  IL-10 induced by PPV may be of importance for the development 
of PMWS in the experimental coinfection of young SFCD pigs 
 
  PMWS-affected pigs appear to have impaired development of 
antibodies to PCV2 
 
  Postweaning colibacillosis is probably not involved in the 
development of PMWS 
 
  Synthetic PO-ODNs representing sequences in the genome of 
PCV2 act inhibitory or stimulatory on IFN-α production by PBMC 
in vitro 
 
  The inhibitory ODN PCV2/1 inhibits IFN-α production induced 
by DNA stimulators but not RNA stimulators 
 
  The IFN-α inhibitory activity of ODN PCV2/1 is dependent on 
the ability to form secondary structures but not the presence of an 
intact CpG dinucleotide 
 
  ODN PCV2/1 inhibits expression of several cytokines in poPBMC 
following stimulation with DNA but not RNA   58 
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Aspects on future work 
In order to better understand the mechanisms behind PCVD, future studies 
are required to further characterize the interaction between PCV2 and the 
immune system of the pig. The work presented in this thesis indicate that 
the genome of PCV2 may contribute to immunomodulatory mechanisms 
used by the virus during infection. Future work should focus on the 
importance of the immunomodulatory motifs in the genome as a whole, and 
ultimately the significance in vivo. Important comparisons can be made with 
the apathogenic PCV1 concerning the presence, location and nature of 
immunomodulatory sequences within the genomes. In addition, possible 
differences between PCV2 genogroups may also be of interest to identify. 
Another area of interest is the humoral immunity to PCV2. Experimental 
coinfection studies could be used to determine whether the apparent 
decreased function of the humoral immunity during PMWS is general or if 
it is specific for the antibody response to PCV2. This could be even more 
interesting if “highly sensitive” pigs, i.e. those with impaired antibody 
production to PCV2 were identified and studied in comparison to pigs with 
unaffected immune functions.  
Although there are still many questions concerning PCV2-infection left 
unanswered, there is little doubt that the interaction with the immune 
system of the pig is of vital importance for the disease process. The events 
leading from the persistent infection of immune cells in clinically healthy 
animals to the severely damaged immune system of PMWS-affected pigs are 
not well known, but the presence of immunomodulatory sequences within 
the genome of PCV2 may contribute to the development. Indeed, the 
different expression of immunoregulatory DNA motifs in Adenovirus 
serotypes 2 and 12 have been reported to influence the immunostimulatory 
activity  in vivo (Krieg et al., 1998) and thus, a regulatory function of 
immunomodulatory sequences in the PCV2 genome is possible.   60 
   61 
References 
Allan, G., McNeilly, F., Meehan, B., McNair, I., Ellis, J., Krakowka, S., Fossum, 
C., Wattrang, E., Wallgren, P. & Adair, B. (2003). Reproduction of postweaning 
multisystemic wasting syndrome in pigs experimentally inoculated with a Swedish 
porcine circovirus 2 isolate. J Vet Diagn Invest 15, 553-60. 
Allan, G. M., McNeilly, F., Cassidy, J. P., Reilly, G. A., Adair, B., Ellis, W. A. & 
McNulty, M. S. (1995). Pathogenesis of porcine circovirus; experimental 
infections of colostrum deprived piglets and examination of pig foetal material. 
Vet Microbiol 44, 49-64. 
Allan, G. M. & Ellis, J. A. (2000). Porcine circoviruses: a review. J Vet Diagn Invest 
12, 3-14. 
Allan, G. M., McNeilly, F., Ellis, J., Krakowka, S., Meehan, B., McNair, I., 
Walker, I. & Kennedy, S. (2000a). Experimental infection of colostrum deprived 
piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory 
syndrome virus (PRRSV) potentiates PCV2 replication. Arch Virol 145, 2421-9. 
Allan, G. M., McNeilly, F., Meehan, B. M., Ellis, J. A., Connor, T. J., McNair, I., 
Krakowka, S. & Kennedy, S. (2000b). A sequential study of experimental 
infection of pigs with porcine circovirus and porcine parvovirus: immunostaining 
of cryostat sections and virus isolation. J Vet Med B Infect Dis Vet Public Health 47, 
81-94. 
Allan, G. M., McNeilly, F., Ellis, J., Krakowka, S., Botner, A., McCullough, K., 
Nauwynck, H., Kennedy, S., Meehan, B. & Charreyre, C. (2004). PMWS: 
experimental model and co-infections. Vet Microbiol 98, 165-8. 
Allan, G. M. & McNeilly, F. (2006). PMWS/PCVD: Diagnosis, disease, and 
control: What do we know? In Proceedings of the19th IPVS Congress, pp. 1-9. 
Copenhagen, Denmark. 
Allan, G. M., McNeilly, F., McMenamy, M., McNair, I., Krakowka, S. G., 
Timmusk, S., Walls, D., Donnelly, M., Minahin, D., Ellis, J., Wallgren, P. & 
Fossum, C. (2007). Temporal distribution of porcine circovirus 2 genogroups 
recovered from postweaning multisystemic wasting syndrome affected and 
nonaffected farms in Ireland and Northern Ireland. J Vet Diagn Invest 19, 668-73. 
Artursson, K., Lindersson, M., Varela, N., Scheynius, A. & Alm, G. V. (1995). 
Interferon-alpha production and tissue localization of interferon-alpha/beta 
6162 
producing cells after intradermal administration of Aujeszky's disease virus-infected 
cells in pigs. Scand J Immunol 41, 121-9. 
Balasch, M., Segales, J., Rosell, C., Domingo, M., Mankertz, A., Urniza, A. & 
Plana-Duran, J. (1999). Experimental inoculation of conventional pigs with tissue 
homogenates from pigs with post-weaning multisystemic wasting syndrome. J 
Comp Pathol 121, 139-48. 
Bave, U., Alm, G. V. & Ronnblom, L. (2000). The combination of apoptotic 
U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol 165, 3519-26. 
Bolin, S. R., Stoffregen, W. C., Nayar, G. P. & Hamel, A. L. (2001). Postweaning 
multisystemic wasting syndrome induced after experimental inoculation of 
cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J Vet 
Diagn Invest 13, 185-94. 
Calsamiglia, M., Fraile, L., Espinal, A., Cuxart, A., Seminati, C., Martin, M., 
Mateu, E., Domingo, M. & Segales, J. (2007). Sow porcine circovirus type 2 
(PCV2) status effect on litter mortality in postweaning multisystemic wasting 
syndrome (PMWS). Res Vet Sci 82, 299-304. 
Chang, H. W., Pang, V. F., Chen, L. J., Chia, M. Y., Tsai, Y. C. & Jeng, C. R. 
(2006). Bacterial lipopolysaccharide induces porcine circovirus type 2 replication 
in swine alveolar macrophages. Vet Microbiol 115, 311-9. 
Charley, B. & Lavenant, L. (1990). Characterization of blood mononuclear cells 
producing IFN alpha following induction by coronavirus-infected cells (porcine 
transmissible gastroenteritis virus). Res Immunol 141, 141-51. 
Charreyre, C., Beseme, S., Brun, A., Bublot, M., Lapostolle, B., Sierra, P. & 
Vaganay, A. (2006). PMWS protection of pigs born to sows vaccinated with an 
inactivated PCV2 vaccine under field conditions. In Proceedings of the 19th IPVS 
Congress, pp. 107. Copenhagen, Denmark. 
Chawla-Sarkar, M., Lindner, D. J., Liu, Y. F., Williams, B. R., Sen, G. C., 
Silverman, R. H. & Borden, E. C. (2003). Apoptosis and interferons: role of 
interferon-stimulated genes as mediators of apoptosis. Apoptosis 8, 237-49. 
Chen, K., Huang, J., Gong, W., Iribarren, P., Dunlop, N. M. & Wang, J. M. 
(2007). Toll-like receptors in inflammation, infection and cancer. Int 
Immunopharmacol 7, 1271-85. 
Cheung, A. K. (2006). Rolling-circle replication of an animal circovirus genome in 
a theta-replicating bacterial plasmid in Escherichia coli. J Virol 80, 8686-94. 
Cheung, A. K., Lager, K. M., Kohutyuk, O. I., Vincent, A. L., Henry, S. C., 
Baker, R. B., Rowland, R. R. & Dunham, A. G. (2007). Detection of two 
porcine circovirus type 2 genotypic groups in United States swine herds. Arch 
Virol 152, 1035-44. 
Clark, E. (1996). Post-weaning multisystemic wasting syndrome. In Proceedings of the 
Western Canadian Association of Swine producers, pp. 19-20. 
Darwich, L., Segales, J., Domingo, M. & Mateu, E. (2002). Changes in CD4(+), 
CD8(+), CD4(+) CD8(+), and immunoglobulin M-positive peripheral blood 
mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs 
and age-matched uninfected wasted and healthy pigs correlate with lesions and   63 
porcine circovirus type 2 load in lymphoid tissues. Clin Diagn Lab Immunol 9, 
236-42. 
Darwich, L., Pie, S., Rovira, A., Segales, J., Domingo, M., Oswald, I. P. & Mateu, 
E. (2003). Cytokine mRNA expression profiles in lymphoid tissues of pigs 
naturally affected by postweaning multisystemic wasting syndrome. J Gen Virol 84, 
2117-25. 
Darwich, L., Segales, J., Resendes, A., Balasch, M., Plana-Duran, J. & Mateu, E. 
(2008). Transient correlation between viremia levels and IL-10 expression in pigs 
subclinically infected with porcine circovirus type 2 (PCV2). Res Vet Sci 84, 194-
198. 
de Boisseson, C., Beven, V., Bigarre, L., Thiery, R., Rose, N., Eveno, E., Madec, 
F. & Jestin, A. (2004). Molecular characterization of Porcine circovirus type 2 
isolates from post-weaning multisystemic wasting syndrome-affected and non-
affected pigs. J Gen Virol 85, 293-304. 
Diaz de Arce, H., Artursson, K., L'Haridon, R., Perers, A., La Bonnardiere, C. & 
Alm, G. V. (1992). A sensitive immunoassay for porcine interferon-alpha. Vet 
Immunol Immunopathol 30, 319-27. 
Domeika, K., Magnusson, M., Eloranta, M. L., Fuxler, L., Alm, G. V. & Fossum, 
C. (2004). Characteristics of oligodeoxyribonucleotides that induce interferon 
(IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet 
Immunol Immunopathol 101, 87-102. 
Dupont, K., Nielsen, E. O., Baekbo, P. & Larsen, L. E. (2008). Genomic analysis of 
PCV2 isolates from Danish archives and a current PMWS case-control study 
supports a shift in genotypes with time. Vet Microbiol 128, 56-64. 
Ellis, J., Hassard, L., Clark, E., Harding, J., Allan, G., Willson, P., Strokappe, J., 
Martin, K., McNeilly, F., Meehan, B., Todd, D. & Haines, D. (1998). Isolation 
of circovirus from lesions of pigs with postweaning multisystemic wasting 
syndrome. Can Vet J 39, 44-51. 
Ellis, J., Clark, E., Haines, D., West, K., Krakowka, S., Kennedy, S. & Allan, G. M. 
(2004). Porcine circovirus-2 and concurrent infections in the field. Vet Microbiol 
98, 159-63. 
Fenaux, M., Halbur, P. G., Gill, M., Toth, T. E. & Meng, X. J. (2000). Genetic 
characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning 
multisystemic wasting syndrome in different geographic regions of North America 
and development of a differential PCR-restriction fragment length polymorphism 
assay to detect and differentiate between infections with PCV-1 and PCV-2. J 
Clin Microbiol 38, 2494-503. 
Fitzgerald-Bocarsly, P. & Feng, D. (2007). The role of type I interferon production 
by dendritic cells in host defense. Biochimie 89, 843-55. 
Fitzgerald-Bocarsly, P., Dai, J. & Singh, S. (2008). Plasmacytoid dendritic cells and 
type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 19, 3-19. 
Fort, M., Olvera, A., Sibila, M., Segales, J. & Mateu, E. (2007). Detection of 
neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-
affected and non-PMWS-affected pigs. Vet Microbiol 125, 244-55. 64 
Garcia-Sastre, A. & Biron, C. A. (2006). Type 1 interferons and the virus-host 
relationship: a lesson in detente. Science 312, 879-82. 
Gilpin, D. F., McCullough, K., Meehan, B. M., McNeilly, F., McNair, I., 
Stevenson, L. S., Foster, J. C., Ellis, J. A., Krakowka, S., Adair, B. M. & Allan, G. 
M. (2003). In vitro studies on the infection and replication of porcine circovirus 
type 2 in cells of the porcine immune system. Vet Immunol Immunopathol 94, 149-
61. 
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., 
Diamond, M. S. & Colonna, M. (2006). Essential role of mda-5 in type I IFN 
responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis 
picornavirus. Proc Natl Acad Sci U S A 103, 8459-64. 
Gobl, A. E., Funa, K. & Alm, G. V. (1988). Different induction patterns of mRNA 
for IFN-alpha and -beta in human mononuclear leukocytes after in vitro 
stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J 
Immunol 140, 3605-9. 
Grau-Roma, L., Crisci, E., Sibila, M., Lopez-Soria, S., Nofrarias, M., Cortey, M., 
Fraile, L., Olvera, A. & Segales, J. (2008). A proposal on porcine circovirus type 2 
(PCV2) genotype definition and their relation with postweaning multisystemic 
wasting syndrome (PMWS) occurrence. Vet Microbiol 128, 23-35. 
Gursel, I., Gursel, M., Ishii, K. J. & Klinman, D. M. (2001). Sterically stabilized 
cationic liposomes improve the uptake and immunostimulatory activity of CpG 
oligonucleotides. J Immunol 167, 3324-8. 
Gursel, M., Gursel, I., Mostowski, H. S. & Klinman, D. M. (2006). CXCL16 
influences the nature and specificity of CpG-induced immune activation. J 
Immunol 177, 1575-80. 
Guzylack-Piriou, L., Balmelli, C., McCullough, K. C. & Summerfield, A. (2004). 
Type-A CpG oligonucleotides activate exclusively porcine natural interferon-
producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and 
interleukin-12. Immunology 112, 28-37. 
Hansmann, L., Groeger, S., von Wulffen, W., Bein, G. & Hackstein, H. (2008). 
Human monocytes represent a competitive source of interferon-alpha in 
peripheral blood. Clin Immunol, doi:10.1016/j.clim.2008.01.014. 
Harding, J. C. (1996). Postweaning multisystemic wasting syndrome: preliminary 
epidemiology and clinical findings. In Proceedings of the Western Canadian 
Association of Swine Productioners, pp. 21. 
Harms, P. A., Sorden, S. D., Halbur, P. G., Bolin, S. R., Lager, K. M., Morozov, I. 
& Paul, P. S. (2001). Experimental reproduction of severe disease in CD/CD pigs 
concurrently infected with type 2 porcine circovirus and porcine reproductive 
and respiratory syndrome virus. Vet Pathol 38, 528-39. 
Haruna, J., Hanna, P., Hurnik, D., Ikede, B., Miller, L. & Yason, C. (2006). The 
role of immunostimulation in the development of postweaning multisystemic 
wasting syndrome in pigs under field conditions. Can J Vet Res 70, 269-76. 
Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, 
S., Zinkernagel, R. & Aguzzi, A. (2004). Lymphoid follicle destruction and   65 
immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat 
Med 10, 187-92. 
Hino, S. & Miyata, H. (2007). Torque teno virus (TTV): current status. Rev Med 
Virol 17, 45-57. 
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. 
& Taniguchi, T. (2005). Spatiotemporal regulation of MyD88-IRF-7 signalling 
for robust type-I interferon induction. Nature 434, 1035-40. 
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., 
Endres, S. & Hartmann, G. (2002). Quantitative expression of toll-like receptor 
1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and 
sensitivity to CpG oligodeoxynucleotides. J Immunol 168, 4531-7. 
Ishii, K. J. & Akira, S. (2006). Innate immune recognition of, and regulation by, 
DNA. Trends Immunol 27, 525-32. 
Ivanov, S., Dragoi, A. M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, 
G., Yap, G. S., Wan, Y., Biron, C. A., Bianchi, M. E., Wang, H. & Chu, W. M. 
(2007). A novel role for HMGB1 in TLR9-mediated inflammatory responses to 
CpG-DNA. Blood 110, 1970-81. 
Iwasaki, A. & Medzhitov, R. (2004). Toll-like receptor control of the adaptive 
immune responses. Nat Immunol 5, 987-95. 
Kamstrup, S., Verthelyi, D. & Klinman, D. M. (2001). Response of porcine 
peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. 
Vet Microbiol 78, 353-62. 
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., 
Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., Yamaguchi, O., Otsu, K., 
Tsujimura, T., Koh, C. S., Reis e Sousa, C., Matsuura, Y., Fujita, T. & Akira, S. 
(2006). Differential roles of MDA5 and RIG-I helicases in the recognition of 
RNA viruses. Nature 441, 101-5. 
Kawai, T. & Akira, S. (2006). Innate immune recognition of viral infection. Nat 
Immunol 7, 131-7. 
Kawashima, K., Katsuda, K. & Tsunemitsu, H. (2007). Epidemiological 
investigation of the prevalence and features of postweaning multisystemic wasting 
syndrome in Japan. J Vet Diagn Invest 19, 60-8. 
Kekarainen, T., Montoya, M., Dominguez, J., Mateu, E. & Segales, J. (2008). 
Porcine circovirus type 2 (PCV2) viral components immunomodulate recall 
antigen responses. Vet Immunol Immunopathol, doi:10.1016/j.vetimm.2008.01.031. 
Kerkmann, M., Costa, L. T., Richter, C., Rothenfusser, S., Battiany, J., Hornung, 
V., Johnson, J., Englert, S., Ketterer, T., Heckl, W., Thalhammer, S., Endres, S. 
& Hartmann, G. (2005). Spontaneous formation of nucleic acid-based 
nanoparticles is responsible for high interferon-alpha induction by CpG-A in 
plasmacytoid dendritic cells. J Biol Chem 280, 8086-93. 
Kim, J. H. & Lyoo, Y. S. (2002). Genetic characterization of porcine circovirus-2 
field isolates from PMWS pigs. J Vet Sci 3, 31-9. 
Klinman, D. M. (2004). Immunotherapeutic uses of CpG oligodeoxynucleotides. 
Nat Rev Immunol 4, 249-58. 66 
Krakowka, S., Ellis, J. A., McNeilly, F., Gilpin, D., Meehan, B., McCullough, K. 
& Allan, G. (2002). Immunologic features of porcine circovirus type 2 infection. 
Viral Immunol 15, 567-82. 
Krakowka, S., Ellis, J., McNeilly, F., Waldner, C., Rings, D. M. & Allan, G. 
(2007). Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 
(PCV2) infection: induction of postweaning multisystemic wasting syndrome 
(PMWS) in the gnotobiotic swine model of PCV2-associated disease. Can Vet J 
48, 716-24. 
Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, 
R., Koretzky, G. A. & Klinman, D. M. (1995). CpG motifs in bacterial DNA 
trigger direct B-cell activation. Nature 374, 546-9. 
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, 
A. K., Short, D. & Davis, H. L. (1998). Sequence motifs in adenoviral DNA 
block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 95, 
12631-6. 
Krieg, A. M. (2007a). Antiinfective applications of toll-like receptor 9 agonists. Proc 
Am Thorac Soc 4, 289-94. 
Krieg, A. M. (2007b). TLR9 and DNA 'feel' RAGE. Nat Immunol 8, 475-7. 
Kritas, S. K., Alexopoulos, C., Kyriakis, C. S., Tzika, E. & Kyriakis, S. C. (2007). 
Performance of fattening pigs in a farm infected with both porcine reproductive 
and respiratory syndrome (PRRS) virus and porcine circovirus type 2 following 
sow and piglet vaccination with an attenuated PRRS vaccine. J Vet Med A Physiol 
Pathol Clin Med 54, 287-91. 
Ladekjaer-Mikkelsen, A. S., Nielsen, J., Stadejek, T., Storgaard, T., Krakowka, S., 
Ellis, J., McNeilly, F., Allan, G. & Botner, A. (2002). Reproduction of 
postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and 
non-immunostimulated 3-week-old piglets experimentally infected with porcine 
circovirus type 2 (PCV2). Vet Microbiol 89, 97-114. 
Larochelle, R., Magar, R. & D'Allaire, S. (2002). Genetic characterization and 
phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases 
presenting various clinical conditions. Virus Res 90, 101-12. 
Lefebvre, D. J., Costers, S., Van Doorsselaere, J., Misinzo, G., Delputte, P. L. & 
Nauwynck, H. J. (2008). Antigenic differences among porcine circovirus type 2 
strains, as demonstrated by the use of monoclonal antibodies. J Gen Virol 89, 177-
87. 
Lekcharoensuk, P., Morozov, I., Paul, P. S., Thangthumniyom, N., Wajjawalku, 
W. & Meng, X. J. (2004). Epitope mapping of the major capsid protein of type 2 
porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol 78, 8135-
45. 
Lenert, P., Goeken, A. J. & Ashman, R. F. (2006). Extended sequence preferences 
for oligodeoxyribonucleotide activity. Immunology 117, 474-81. 
Lipford, G. B., Sparwasser, T., Zimmermann, S., Heeg, K. & Wagner, H. (2000). 
CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 
predisposition to antigen-driven responses. J Immunol 165, 1228-35.   67 
Liu, J., Chen, I. & Kwang, J. (2005). Characterization of a previously unidentified 
viral protein in porcine circovirus type 2-infected cells and its role in virus-
induced apoptosis. J Virol 79, 8262-74. 
Liu, J., Zhu, Y., Chen, I., Lau, J., He, F., Lau, A., Wang, Z., Karuppannan, A. K. 
& Kwang, J. (2007). The ORF3 protein of porcine circovirus type 2 interacts 
with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral 
infection. J Virol 81, 9560-7. 
Lundberg, P., Welander, P., Han, X. & Cantin, E. (2003). Herpes simplex virus 
type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 77, 11158-69. 
Madec, F., Rose, N., Eveno, E., Morvan, P., Larour, G., Jolly, J. P., Le Diguerher, 
G., Cariolet, R., Le Dimna, M., Blanchard, P. & Jestin, A. (2001). PMWS: on-
farm observations and preliminary analytic epidemiology. In Proceedings of 
Conference on ssDNA Viruses of Plants, Birds, Pigs and Primates. Saint-Malo, France. 
Madec, F., Eveno, E., Morvan, P., Hamon, L., Blanchard, P., Cariolet, R., 
Amenna, N., Morvan, H., Truong, C., Mahé, D., Albina, E., Jestin, A. (2000). 
Post-weaning multisystemic wasting syndrome (PMWS) in pigs in France: clinical 
observations from follow-up studies on affected farms. Livestock Prod Sci 63, 223-
233. 
Magar, R., Larochelle, R., Thibault, S. & Lamontagne, L. (2000a). Experimental 
transmission of porcine circovirus type 2 (PCV2) in weaned pigs: a sequential 
study. J Comp Pathol 123, 258-69. 
Magar, R., Muller, P. & Larochelle, R. (2000b). Retrospective serological survey of 
antibodies to porcine circovirus type 1 and type 2. Can J Vet Res 64, 184-6. 
Magnusson, M., Magnusson, S., Vallin, H., Ronnblom, L. & Alm, G. V. (2001). 
Importance of CpG dinucleotides in activation of natural IFN-alpha-producing 
cells by a lupus-related oligodeoxynucleotide. Scand J Immunol 54, 543-50. 
Mahe, D., Blanchard, P., Truong, C., Arnauld, C., Le Cann, P., Cariolet, R., 
Madec, F., Albina, E. & Jestin, A. (2000). Differential recognition of ORF2 
protein from type 1 and type 2 porcine circoviruses and identification of 
immunorelevant epitopes. J Gen Virol 81, 1815-24. 
Mankertz, A., Caliskan, R., Hattermann, K., Hillenbrand, B., Kurzendoerfer, P., 
Mueller, B., Schmitt, C., Steinfeldt, T. & Finsterbusch, T. (2004). Molecular 
biology of Porcine circovirus: analyses of gene expression and viral replication. Vet 
Microbiol 98, 81-8. 
McKeown, N. E., Opriessnig, T., Thomas, P., Guenette, D. K., Elvinger, F., 
Fenaux, M., Halbur, P. G. & Meng, X. J. (2005). Effects of porcine circovirus 
type 2 (PCV2) maternal antibodies on experimental infection of piglets with 
PCV2. Clin Diagn Lab Immunol 12, 1347-51. 
Meehan, B. M., Creelan, J. L., McNulty, M. S. & Todd, D. (1997). Sequence of 
porcine circovirus DNA: affinities with plant circoviruses. J Gen Virol 78 ( Pt 1), 
221-7. 
Meehan, B. M., McNeilly, F., Todd, D., Kennedy, S., Jewhurst, V. A., Ellis, J. A., 
Hassard, L. E., Clark, E. G., Haines, D. M. & Allan, G. M. (1998). 
Characterization of novel circovirus DNAs associated with wasting syndromes in 
pigs. J Gen Virol 79 ( Pt 9), 2171-9. 68 
Meerts, P., Misinzo, G. & Nauwynck, H. J. (2005a). Enhancement of porcine 
circovirus 2 replication in porcine cell lines by IFN-gamma before and after 
treatment and by IFN-alpha after treatment. J Interferon Cytokine Res 25, 684-93. 
Meerts, P., Van Gucht, S., Cox, E., Vandebosch, A. & Nauwynck, H. J. (2005b). 
Correlation between type of adaptive immune response against porcine circovirus 
type 2 and level of virus replication. Viral Immunol 18, 333-41. 
Meerts, P., Misinzo, G., Lefebvre, D., Nielsen, J., Botner, A., Kristensen, C. S. & 
Nauwynck, H. J. (2006). Correlation between the presence of neutralizing 
antibodies against porcine circovirus 2 (PCV2) and protection against replication 
of the virus and development of PCV2-associated disease. BMC Vet Res 2, 6. 
Melin, L. & Wallgren, P. (2002). Aspects on feed related prophylactic measures 
aiming to prevent post weaning diarrhoea in pigs. Acta Vet Scand 43, 231-45. 
Melin, L., Mattsson, S., Katouli, M. & Wallgren, P. (2004). Development of post-
weaning diarrhoea in piglets. Relation to presence of Escherichia coli strains and 
rotavirus. J Vet Med B Infect Dis Vet Public Health 51, 12-22. 
Mena, A., Nichani, A. K., Popowych, Y., Ioannou, X. P., Godson, D. L., Mutwiri, 
G. K., Hecker, R., Babiuk, L. A. & Griebel, P. (2003). Bovine and ovine blood 
mononuclear leukocytes differ markedly in innate immune responses induced by 
Class A and Class B CpG-oligodeoxynucleotide. Oligonucleotides 13, 245-59. 
Meylan, E. & Tschopp, J. (2006). Toll-like receptors and RNA helicases: two 
parallel ways to trigger antiviral responses. Mol Cell 22, 561-9. 
Misinzo, G., Meerts, P., Bublot, M., Mast, J., Weingartl, H. M. & Nauwynck, H. 
J. (2005). Binding and entry characteristics of porcine circovirus 2 in cells of the 
porcine monocytic line 3D4/31. J Gen Virol 86, 2057-68. 
Misinzo, G., Delputte, P. L., Meerts, P., Lefebvre, D. J. & Nauwynck, H. J. (2006). 
Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B 
glycosaminoglycans as receptors for its attachment to host cells. J Virol 80, 3487-
94. 
Misinzo, G., Delputte, P. L., Lefebvre, D. J. & Nauwynck, H. J. (2008a). Increased 
yield of porcine circovirus-2 by a combined treatment of PK-15 cells with 
interferon-gamma and inhibitors of endosomal-lysosomal system acidification. 
Arch Virol 153, 337-42. 
Misinzo, G., Delputte, P. L. & Nauwynck, H. J. (2008b). Inhibition of endosome-
lysosome system acidification enhances porcine circovirus 2 infection of porcine 
epithelial cells. J Virol 82, 1128-35. 
Mutwiri, G., Pontarollo, R., Babiuk, S., Griebel, P., van Drunen Littel-van den 
Hurk, S., Mena, A., Tsang, C., Alcon, V., Nichani, A., Ioannou, X., Gomis, S., 
Townsend, H., Hecker, R., Potter, A. & Babiuk, L. A. (2003). Biological activity 
of immunostimulatory CpG DNA motifs in domestic animals. Vet Immunol 
Immunopathol 91, 89-103. 
Nayar, G. P., Hamel, A. L., Lin, L., Sachvie, C., Grudeski, E. & Spearman, G. 
(1999). Evidence for circovirus in cattle with respiratory disease and from aborted 
bovine fetuses. Can Vet J 40, 277-8. 
Nielsen, J., Vincent, I. E., Botner, A., Ladekaer-Mikkelsen, A. S., Allan, G., 
Summerfield, A. & McCullough, K. C. (2003). Association of lymphopenia with   69 
porcine circovirus type 2 induced postweaning multisystemic wasting syndrome 
(PMWS). Vet Immunol Immunopathol 92, 97-111. 
Nowacki, W. & Charley, B. (1993). Enrichment of coronavirus-induced 
interferon-producing blood leukocytes increases the interferon yield per cell: a 
study with pig leukocytes. Res Immunol 144, 111-20. 
Okuda, Y., Ono, M., Yazawa, S. & Shibata, I. (2003). Experimental reproduction 
of postweaning multisystemic wasting syndrome in cesarean-derived, colostrum-
deprived piglets inoculated with porcine circovirus type 2 (PCV2): investigation 
of quantitative PCV2 distribution and antibody responses. J Vet Diagn Invest 15, 
107-14. 
Olvera, A., Cortey, M. & Segales, J. (2007). Molecular evolution of porcine 
circovirus type 2 genomes: phylogeny and clonality. Virology 357, 175-85. 
Opriessnig, T., Thacker, E. L., Yu, S., Fenaux, M., Meng, X. J. & Halbur, P. G. 
(2004). Experimental reproduction of postweaning multisystemic wasting 
syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine 
circovirus type 2. Vet Pathol 41, 624-40. 
Opriessnig, T., McKeown, N. E., Harmon, K. L., Meng, X. J. & Halbur, P. G. 
(2006a). Porcine circovirus type 2 infection decreases the efficacy of a modified 
live porcine reproductive and respiratory syndrome virus vaccine. Clin Vaccine 
Immunol 13, 923-9. 
Opriessnig, T., McKeown, N. E., Zhou, E. M., Meng, X. J. & Halbur, P. G. 
(2006b). Genetic and experimental comparison of porcine circovirus type 2 
(PCV2) isolates from cases with and without PCV2-associated lesions provides 
evidence for differences in virulence. J Gen Virol 87, 2923-32. 
Opriessnig, T., Meng, X. J. & Halbur, P. G. (2007). Porcine circovirus type 2 
associated disease: update on current terminology, clinical manifestations, 
pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest 19, 591-615. 
Ostanello, F., Caprioli, A., Di Francesco, A., Battilani, M., Sala, G., Sarli, G., 
Mandrioli, L., McNeilly, F., Allan, G. M. & Prosperi, S. (2005). Experimental 
infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus 
type 2 and porcine parvovirus. Vet Microbiol 108, 179-86. 
Parra, M. D., Fuentes, P., Tecles, F., Martinez-Subiela, S., Martinez, J. S., Munoz, 
A. & Ceron, J. J. (2006). Porcine acute phase protein concentrations in different 
diseases in field conditions. J Vet Med B Infect Dis Vet Public Health 53, 488-93. 
Pisetsky, D. S. & Reich, C. F. (2000). Inhibition of murine macrophage IL-12 
production by natural and synthetic DNA. Clin Immunol 96, 198-204. 
Pogranichnyy, R. M., Yoon, K. J., Harms, P. A., Swenson, S. L., Zimmerman, J. J. 
& Sorden, S. D. (2000). Characterization of immune response of young pigs to 
porcine circovirus type 2 infection. Viral Immunol 13, 143-53. 
Rose, N., Larour, G., Le Diguerher, G., Eveno, E., Jolly, J. P., Blanchard, P., 
Oger, A., Le Dimna, M., Jestin, A. & Madec, F. (2003). Risk factors for porcine 
post-weaning multisystemic wasting syndrome (PMWS) in 149 French farrow-to-
finish herds. Prev Vet Med 61, 209-25. 
Rose, N., Blanchard, P., Cariolet, R., Grasland, B., Amenna, N., Oger, A., 
Durand, B., Balasch, M., Jestin, A. & Madec, F. (2007). Vaccination of porcine 70 
circovirus type 2 (PCV2)-infected sows against porcine Parvovirus (PPV) and 
Erysipelas: effect on post-weaning multisystemic wasting syndrome (PMWS) and 
on PCV2 genome load in the offspring. J Comp Pathol 136, 133-44. 
Samuel, C. E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14, 778-
809, table of contents. 
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M. D., Silverman, G. 
J., Lotz, M., Carson, D. A. & Raz, E. (1996). Immunostimulatory DNA 
sequences necessary for effective intradermal gene immunization. Science 273, 352-
4. 
Segales, J., Alonso, F., Rosell, C., Pastor, J., Chianini, F., Campos, E., Lopez-
Fuertes, L., Quintana, J., Rodriguez-Arrioja, G., Calsamiglia, M., Pujols, J., 
Dominguez, J. & Domingo, M. (2001). Changes in peripheral blood leukocyte 
populations in pigs with natural postweaning multisystemic wasting syndrome 
(PMWS). Vet Immunol Immunopathol 81, 37-44. 
Segales, J. & Domingo, M. (2002). Postweaning multisystemic wasting syndrome 
(PMWS) in pigs. A review. Vet Q 24, 109-24. 
Segales, J., Domingo, M., Chianini, F., Majo, N., Dominguez, J., Darwich, L. & 
Mateu, E. (2004a). Immunosuppression in postweaning multisystemic wasting 
syndrome affected pigs. Vet Microbiol 98, 151-8. 
Segales, J., Pineiro, C., Lampreave, F., Nofrarias, M., Mateu, E., Calsamiglia, M., 
Andres, M., Morales, J., Pineiro, M. & Domingo, M. (2004b). Haptoglobin and 
pig-major acute protein are increased in pigs with postweaning multisystemic 
wasting syndrome (PMWS). Vet Res 35, 275-82. 
Segales, J., Allan, G. M. & Domingo, M. (2005). Porcine circovirus diseases. Anim 
Health Res Rev 6, 119-42. 
Shi, K., Li, H., Guo, X., Ge, X., Jia, H., Zheng, S. & Yang, H. (2007). Changes in 
peripheral blood leukocyte subpopulations in piglets co-infected experimentally 
with porcine reproductive and respiratory syndrome virus and porcine circovirus 
type 2. Vet Microbiol, doi:10.1016/j.vetmic.2007.11.020. 
Shuai, J., Wei, W., Li, X., Chen, N., Zhang, Z., Chen, X. & Fang, W. (2007). 
Genetic characterization of porcine circovirus type 2 (PCV2) from pigs in high-
seroprevalence areas in southeastern China. Virus Genes 35, 619-27. 
Sipos, W., Duvigneau, J. C., Willheim, M., Schilcher, F., Hartl, R. T., Hofbauer, 
G., Exel, B., Pietschmann, P. & Schmoll, F. (2004). Systemic cytokine profile in 
feeder pigs suffering from natural postweaning multisystemic wasting syndrome 
(PMWS) as determined by semiquantitative RT-PCR and flow cytometric 
intracellular cytokine detection. Vet Immunol Immunopathol 99, 63-71. 
Stein, C. A., Subasinghe, C., Shinozuka, K. & Cohen, J. S. (1988). 
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic 
Acids Res 16, 3209-21. 
Steinfeldt, T., Finsterbusch, T. & Mankertz, A. (2006). Demonstration of 
nicking/joining activity at the origin of DNA replication associated with the rep 
and rep' proteins of porcine circovirus type 1. J Virol 80, 6225-34. 
Stevenson, L. S., McCullough, K., Vincent, I., Gilpin, D. F., Summerfield, A., 
Nielsen, J., McNeilly, F., Adair, B. M. & Allan, G. M. (2006). Cytokine and C-  71 
reactive protein profiles induced by porcine circovirus type 2 experimental 
infection in 3-week-old piglets. Viral Immunol 19, 189-95. 
Stevenson, L. S., Gilpin, D. F., Douglas, A., McNeilly, F., McNair, I., Adair, B. M. 
& Allan, G. M. (2007). T lymphocyte epitope mapping of porcine circovirus type 
2. Viral Immunol 20, 389-98. 
Stunz, L. L., Lenert, P., Peckham, D., Yi, A. K., Haxhinasto, S., Chang, M., Krieg, 
A. M. & Ashman, R. F. (2002). Inhibitory oligonucleotides specifically block 
effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32, 1212-22. 
Summerfield, A., Guzylack-Piriou, L., Schaub, A., Carrasco, C. P., Tache, V., 
Charley, B. & McCullough, K. C. (2003). Porcine peripheral blood dendritic cells 
and natural interferon-producing cells. Immunology 110, 440-9. 
Svensson, H., Johannisson, A., Nikkila, T., Alm, G. V. & Cederblad, B. (1996). 
The cell surface phenotype of human natural interferon-alpha producing cells as 
determined by flow cytometry. Scand J Immunol 44, 164-72. 
Takaoka, A. & Taniguchi, T. (2007). Cytosolic DNA recognition for triggering 
innate immune responses. Adv Drug Deliv Rev, doi:10.1016/j.addr.2007.12.002. 
Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., 
Miyagishi, M., Kodama, T., Honda, K., Ohba, Y. & Taniguchi, T. (2007). DAI 
(DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune 
response. Nature 448, 501-5. 
Takeuchi, O. & Akira, S. (2008). MDA5/RIG-I and virus recognition. Curr Opin 
Immunol 20, 17-22. 
Theofilopoulos, A. N., Baccala, R., Beutler, B. & Kono, D. H. (2005). Type I 
interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23, 
307-36. 
Tian, J., Avalos, A. M., Mao, S. Y., Chen, B., Senthil, K., Wu, H., Parroche, P., 
Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L. L., Audoly, L., La Rosa, G., 
Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow, M. K., Fitzgerald, K. 
A., Latz, E., Kiener, P. A. & Coyle, A. J. (2007). Toll-like receptor 9-dependent 
activation by DNA-containing immune complexes is mediated by HMGB1 and 
RAGE. Nat Immunol 8, 487-96. 
Timmusk, S., Wallgren, P., Brunborg, I. M., Wikstrom, F. H., Allan, G., Meehan, 
B., McMenamy, M., McNeilly, F., Fuxler, L., Belak, K., Podersoo, D., Saar, T., 
Berg, M. & Fossum, C. (2008). Phylogenetic analysis of porcine circovirus type 2 
(PCV2) pre- and post-epizootic postweaning multisystemic wasting syndrome 
(PMWS). Virus Genes, doi:10.1007/s11262-008-0217-1. 
Tischer, I., Rasch, R. & Tochtermann, G. (1974). Characterization of papovavirus-
and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl 
Bakteriol [Orig A] 226, 153-67. 
Tischer, I., Gelderblom, H., Vettermann, W. & Koch, M. A. (1982). A very small 
porcine virus with circular single-stranded DNA. Nature 295, 64-6. 
Tischer, I., Mields, W., Wolff, D., Vagt, M. & Griem, W. (1986). Studies on 
epidemiology and pathogenicity of porcine circovirus. Arch Virol 91, 271-6. 
Todd, D. (2004). Avian circovirus diseases: lessons for the study of PMWS. Vet 
Microbiol 98, 169-74. 72 
Trieu, A., Roberts, T. L., Dunn, J. A., Sweet, M. J. & Stacey, K. J. (2006). DNA 
Motifs Suppressing TLR9 Responses. Crit Rev Immunol 26, 527-44. 
Truong, C., Mahe, D., Blanchard, P., Le Dimna, M., Madec, F., Jestin, A. & 
Albina, E. (2001). Identification of an immunorelevant ORF2 epitope from 
porcine circovirus type 2 as a serological marker for experimental and natural 
infection. Arch Virol 146, 1197-211. 
Tudor, D., Dubuquoy, C., Gaboriau, V., Lefevre, F., Charley, B. & Riffault, S. 
(2005). TLR9 pathway is involved in adjuvant effects of plasmid DNA-based 
vaccines. Vaccine 23, 1258-64. 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. 
& Speleman, F. (2002). Accurate normalization of real-time quantitative RT-
PCR data by geometric averaging of multiple internal control genes. Genome Biol 
3, RESEARCH0034. 
Vigre, H., Baekbo, P., Jorsal, S. E., Bille-Hansen, V., Hassing, A. G., Enoe, C. & 
Botner, A. (2005). Spatial and temporal patterns of pig herds diagnosed with 
Postweaning Multisystemic Wasting Syndrome (PMWS) during the first two years 
of its occurrence in Denmark. Vet Microbiol 110, 17-26. 
Vincent, I. E., Carrasco, C. P., Herrmann, B., Meehan, B. M., Allan, G. M., 
Summerfield, A. & McCullough, K. C. (2003). Dendritic cells harbor infectious 
porcine circovirus type 2 in the absence of apparent cell modulation or replication 
of the virus. J Virol 77, 13288-300. 
Vincent, I. E., Carrasco, C. P., Guzylack-Piriou, L., Herrmann, B., McNeilly, F., 
Allan, G. M., Summerfield, A. & McCullough, K. C. (2005). Subset-dependent 
modulation of dendritic cell activity by circovirus type 2. Immunology 115, 388-98. 
Vincent, I. E., Balmelli, C., Meehan, B., Allan, G., Summerfield, A. & 
McCullough, K. C. (2007). Silencing of natural interferon producing cell 
activation by porcine circovirus type 2 DNA. Immunology 120, 47-56. 
Wallgren, P., Hasslung, F., Bergstrom, G., Linder, A., Belak, K., Hard af Segerstad, 
C., Stampe, M., Molander, B., Bjornberg Kallay, T., Norregard, E., Ehlorsson, C. 
J., Tornquist, M., Fossum, C., Allan, G. M. & Robertsson, J. A. (2004). 
Postweaning multisystemic wasting syndrome--PMWS. the first year with the 
disease in Sweden. Vet Q 26, 170-87. 
Wallgren, P., Belák, K., Ehlorsson, C.-J., Bergström, G., Lindberg, M., Fossum, C., 
Allan, G.M. & Robertsson, J.Å. (2007). Postweaning Multisystemic Wasting 
Syndrome (PMWS) in Sweden. From an exotic to an endemic disease. Vet Q 29, 
122-137. 
Wang, Z., Choi, M. K., Ban, T., Yanai, H., Negishi, H., Lu, Y., Tamura, T., 
Takaoka, A., Nishikura, K. & Taniguchi, T. (2008). Regulation of innate 
immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. 
Proc Natl Acad Sci U S A 105, 5477-82. 
Wattrang, E., McNeilly, F., Allan, G. M., Greko, C., Fossum, C. & Wallgren, P. 
(2002). Exudative epidermitis and porcine circovirus-2 infection in a Swedish 
SPF-herd. Vet Microbiol 86, 281-93. 
Wattrang, E., Palm, A.-K. & Wagner, B. (2006). In vitro stimulation of equine 
leukocytes with CpG-oligodeoxyribonucleotides - Cytokine production and   73 
proliferation. In Proceedings of the 8th International Veterinary Immunology Symposium, 
pp. 130. Ouro Preto, Brazil. 
Wellenberg, G. J., Stockhofe-Zurwieden, N., Boersma, W. J., De Jong, M. F. & 
Elbers, A. R. (2004). The presence of co-infections in pigs with clinical signs of 
PMWS in The Netherlands: a case-control study. Res Vet Sci 77, 177-84. 
Woodbine, K. A., Medley, G. F., Slevin, J., Kilbride, A. L., Novell, E. J., Turner, 
M. J., Keeling, M. J. & Green, L. E. (2007). Spatiotemporal patterns and risks of 
herd breakdowns in pigs with postweaning multisystemic wasting syndrome. Vet 
Rec 160, 751-62. 
Wu, C. C., Lee, J., Raz, E., Corr, M. & Carson, D. A. (2004). Necessity of 
oligonucleotide aggregation for toll-like receptor 9 activation. J Biol Chem 279, 
33071-8. 
Xu, Y. & Szoka, F. C., Jr. (1996). Mechanism of DNA release from cationic 
liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-23. 
Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T. 
& Tokunaga, T. (1992). DNA from bacteria, but not from vertebrates, induces 
interferons, activates natural killer cells and inhibits tumor growth. Microbiol 
Immunol 36, 983-97. 
Yasuda, K., Rutz, M., Schlatter, B., Metzger, J., Luppa, P. B., Schmitz, F., Haas, 
T., Heit, A., Bauer, S. & Wagner, H. (2006). CpG motif-independent activation 
of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. Eur J 
Immunol 36, 431-6. 
Zhao, H., Cheng, S. H. & Yew, N. S. (2000). Requirements for effective 
inhibition of immunostimulatory CpG motifs by neutralizing motifs. Antisense 
Nucleic Acid Drug Dev 10, 381-9. 
   74 
   75 
Acknowledgements 
The work of this thesis was performed at the department of Biomedical 
Sciences and Veterinary Public Health, Division of Immunology, with 
support from the Program for Biology of Infection at the Faculty of 
Veterinary Medicine and Animal Science, FORMAS, SLF, EU (FOOD-
CT-2004-513928) and Merial. 
 
Det är många som har hjälpt och stöttat mig genom åren och bidragit till 
arbetet med den här avhandlingen, och jag skulle vilja rikta ett speciellt tack 
till några av dessa:  
 
Caroline Fossum, min huvudhandledare och den drivande kraften bakom 
hela projektet. Tack för all uppmuntran, diskussioner om allt möjligt i den 
röda soffan och ditt stora engagemang.  
Per Wallgren, biträdande handledare, guru på svinmedicin och inspiratör. 
Tack för intressanta resor i och utanför Sverige, med och utan grisar i bilen. 
Jag har aldrig haft tråkigt!  
Eva Wattrang, biträdande handledare och god vän som ställer upp i alla 
lägen. Tack för att du gärna delar med dig av ditt skarpsinne i forskningen 
och för att du alltid tar dig tid med frågor, stora som små. 
Mikael Berg, biträdande handledare och den som förstår allt det där 
molekylära med virus som kan vara lite komplicerat… Tack för hjälp och 
idéer. 
Gunnar Alm, biträdande handledare och oersättlig resurs i form av 
immunologisk kunskap. 
Lisbeth Bettan Fuxler, vår klippa som har lärt mig allt jag kan om 
laborativt arbete. Tack för alla roliga stunder i och utanför labbet, och för all 
hjälp och stöd i stort som smått. 76
Tanja Lövgren, senior forskare, rumskamrat och god vän som alltid ställer
upp. Molekylärbiologisk brain trust med ett siamesiskt sinne för humor.
Lotta Wik, rumsgranne, doktorandkollega, dinosariemamma och del av
den molekylärbiologiska brain trusten. Tommy Linné och Kersti Larsson
som utgör stommen på avdelningen.
Alla som varit på avdelningen genom åren och bidragit till samarbeten,
gott humör, fredagsfika, biokvällar och många andra viktiga funktioner; Sirje
Timmusk, Mikael Klingeborn, Elodie  Merlot,  Märit  Andersson,  Anne
Trönnberg, Maija-Leena Eloranta, Anders Perers, Mattias  Magnusson,
Kristina Domeika, Judith Martin,  Jonas Wensman, Anne-Lie Blomström,
Josefine Elving, Cecilia Wolff, Dieter Fuchs, Stina Blomberg, Ullvi Båve,
Lisa Sundblad och Elina Sandwall.
Alla på SVA som på ett eller annat sätt blivit involverade i våra projekt
och bidragit med stor hjälp och kunskap; Maja Persson, Sigbrit Mattsson,
Lennart Melin, Katinka Belák, Gunilla Blomqvist, Per Carlsson, Mate
Zoric, Thomas Segall och Barbro Högberg.
Anna Lundén som tillsammans med Mikael Berg koordinerat och
organiserat infektionsbiologiprogrammet.
Ulla Schmidt och alla grisarna på Lövsta som har ställt upp genom åren.
The Belfast group, Gordon Allan, Francis McNeilly, Irene McNair,
Leanne Stevenson, Deirdre Gilpin and Paula Lagan-Tregaskis for  welcoming
me to Northern Ireland and being an invaluable and generous resource in the
scientific world of PCV.
The EU-people, in particular Laurie Reid, for the splendid meetings at
fantastic locations in Europe.
Brian Meehan for inspiring ideas and input on manuscripts that was vital
for the successful publications.
Jenny Reimer, vän och doktorandkollega som vet hur det är och alltid
har tid att lyssna.
Uppsala  Akademiska Roddarsällskap (UARS), klubben med det stora
hjärtat.
Min svär-familj; Ingrid, Allan, Kenneth och Malin
Mina föräldrar, Karin och Lennart, och min syster  Linnea för  att ni finns
utanför den akademiska världen.
Peter och Elin för att ni är precis som ni är.